Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Oct 3;13:954938. doi: 10.3389/fphar.2022.954938

Roles and mechanisms of garlic and its extracts on atherosclerosis: A review

Min Li 1,, Wingyan Yun 1,2,, Guibin Wang 1, Anqi Li 1,2, Jing Gao 1,2, Qingyong He 1,*
PMCID: PMC9574545  PMID: 36263122

Abstract

The prevention and treatment of cardiovascular diseases (CVDs) have achieved initial results, but the number of CVDs patients will increase rapidly in the next 10 years. Atherosclerosis (AS) is a significant risk factor for CVDs. The impact of lifestyle and daily diet varies considerably between different countries and continents and has been shown to affect the development of various diseases such as diabetes and CVDs. Primary and secondary prevention using alternative supplements and methods to avoid or reduce the use of traditional pharmacological drugs have also become popular. One of the reasons for this is that pharmacological drugs with lipid-lowering, and blood pressure-lowering effects cause many side effects that may negatively impact the quality of life. Patients are now emphasizing reliance on lifestyle changes to reduce cardiovascular risks. Garlic is a medicinal and edible plant that has been used for a long time. In order to reveal garlic application in the prevention and treatment of AS, reviewing the latest domestic and international studies through searching databases. The result shows that the antiatherogenic role of garlic is eximious. And the mechanisms are mainly related to hypolipidemic, antioxidant, antithrombotic, inhibiting angiogenesis, protecting endothelial cells, anti-inflammatory, anti-apoptotic, inhibiting vascular smooth muscle proliferation, and regulating gut microbiota. The main signaling pathways involve AMPK/TLRs, Keap1/Nrf2, PI3K/AKT, PPARγ/LXRα, GEF-H1/RhoA/Rac, etc. The antiatherogenic actions and molecular mechanism of garlic were reviewed in this study to obtain a robust evidence basis for the clinical application and mechanistic study and provide a theoretical basis for further utilization of garlic.

Keywords: garlic, Allium sativum, atherosclerosis, oxidative stress, inflammation, endothelial dysfunction

Introduction

Atherosclerosis is a lipid-driven chronic inflammatory disease and increases morbidity and mortality of CVDs. Inflammation and abnormal lipid metabolism underlie the pathology of AS, mainly involving the inner and middle layers of arteries, resulting in thickening and stiffening of the arterial wall, narrowing of the lumen, and progressive loss of elasticity. Low-density lipoprotein (LDL) accumulates in blood vessels, causing monocytes to phagocytize. The foam cells formed by monocyte phagocytosis of LDL are prone to rupture. The released necrotic products stimulate the proliferation of fibrous tissue, forming fibrous plaques, which continue to develop into atheromatous plaques and eventually lead to AS.

CVDs are the leading cause of death from disease in China (Zhao et al., 2019) and are expected to cause 3 million deaths by 2030 (HALE Collaborators, 2017). The prevalence of CVDs in China is continuously rising, with an estimated 330 million people currently suffering from with CVDs (China Cardiovascular Health and Disease Report Writing Group, 2021). Lately, there has been increased interest and awareness in society regarding the connection between dietary intake and diseases. One of the reasons for this is that pharmacological drugs with lipid-lowering, and blood pressure-lowering effects cause many side effects that may negatively impact the quality of life.

Natural products, such as Chinese herbs, are an ideal source for developing safe and effective drugs for AS (Liu et al., 2015). Herbal or botanical preparations [complementary and alternative medicine (CAM)] have gained tremendous popularity in healthcare maintenance. A large number of populations in both developing and developed countries prefer to use CAM as a treatment and preventive measure for diseases (Qidwai et al., 2003; Frass et al., 2012). The 2007 National Health Interview Survey (NHIS) reported that approximately 38% of United States adults and 12% of children used CAM in the past 12 months; the usage rate of CAM has increased steadily all over the world since 1950 (Barnes et al., 2008; Omeish et al., 2011).

Garlic (Allium sativum) is the underground bulb of Allium sativum L., a member of the broad lily family. The hypolipidemic, antiatherogenic, anticoagulant, antidiabetic, antihypertensive, antimicrobial, anticancer, antioxidant, and immunomodulatory activities of garlic have been fully confirmed in basic and clinical research (HALE Collaborators, 2017). Aged garlic extract (AGE) inhibits coronary artery calcification progression, glucose levels, and blood pressure in patients at increased risk of cardiovascular events in a European cohort (Wlosinska et al., 2020). Phytochemical content in garlic could be a promising therapeutic agent in the future for the treatment of CVDs. Organosulfur compounds are the main active constituents of garlic, although the mechanism remains unclear (Gardner et al., 2007). In this study, the pharmacological effects of garlic and related mechanisms were reviewed to reveal its application in the prevention and treatment of AS.

Materials and methods

Four databases of Chinese periodicals and three databases of English are searched comprehensively: China National Knowledge Infrastructure (CNKI, https://www.cnki.net/), Chinese Scientific Journals Full-Text Database (VIP, http://www.cqvip.com/), Wanfang Journal Database (WAN FANG, http://www.wanfangdata.com.cn/index.html) and China Biological Medicine Database (Sinomed, http://www.sinomed.ac.cn/), Pubmed (https://pubmed.ncbi.nlm.nih.gov/), Web of Science (http://isiknowledge.com), and Web of Science (https://www.webofscience.com). Studies on garlic for AS were screened from database construction to May 2022. The complete search strategy is attached (Supplementary Appendix A1). The search was conducted by two searchers using MeSH terms and entry terms. Two evaluators independently screened, evaluated, and cross-checked the literature according to the inclusion/exclusion criteria and consulted a third party to assist in discussing and resolving any disagreements.

Inclusion criteria

The following types of studies were included: The following types of studies were included: 1) experimental studies; 2) clinical trials; 3) not a case report or a review; and 4) medicine identified as garlic or the garlic extract.

Exclusion criteria

The following types of studies were excluded: The following types of studies were excluded: 1) full text not available; and 2) treatments combined with other ingredients.

Results

Based on the screening results, 6870 studies were retrieved, and after excluding duplicate and irrelevant studies, 610 cases remained, and 48 unrelated studies were excluded after reading the titles and abstracts. 219 cases were excluded from reading the full text, of which 126 cases did not meet the inclusion criteria, 93 cases were comments, and finally, 343 cases were included, including 201 in vivo experiments, 63 in vitro experiments, seven in vivo experiments and in vitro experiments, and 72 clinical experiments. The retrieval process is shown in Figure 1.

FIGURE 1.

FIGURE 1

Summary of the literature search process.

Botanical characteristics of garlic

Garlic is a biennial herb, that is, oblate or short conical in shape, with grayish or light brown membranous scale skin on the outside. Garlic has 6–10 cloves inside the bulbous leaves, borne in whorls around the flowering stem, with a disc-shaped stem base and numerous fibrous roots. Each garlic clove is covered with a membrane, peeled off to reveal white, thick, and juicy scales. It has a strong garlic odor and a pungent taste. Garlic leaves are solid, flat, linear-lanceolate, about 2.5 cm wide, and sheath-like at the base. The flowering stem is erect, about 60 cm high, the spathe has a long beak, 7–10 cm long, and the flowering period is 5–6 months. The bulbs are usually dug in spring and summer and used fresh or dried (Figure 2).

FIGURE 2.

FIGURE 2

(A) Garlic plants. (B) Garlic bulbs. (C) Peeled garlic cloves.

History of garlic

Garlic is widely cultivated in Asia, Africa, and Europe (Tocmo et al., 2017). The Central Asian region is the origin of garlic. There are five species of garlic germplasm in the world, namely, Sativum, Ophioscorodon, Longicuspis, Subtropical, and Pekinense, of which Longicuspis is the most primitive, and other species are differentiated from it (Kamenetsky et al., 2005). Garlic was introduced to mainland China from Xinjiang during the Han Dynasty (Block, 1985). Xinjiang garlic is known as high alliin garlic because of its high active ingredients. The medicinal function of garlic can be traced back to 4000 years ago. At that time, garlic was used as an antiseptic and a stimulant, and the Chinese used garlic to treat exogenous fevers and headaches (Nagini, 2008). Consumption of fresh, cooked garlic is considered safe by the FDA (Rouf et al., 2020). Garlic is known for its wide range of biological activities, including anti-inflammatory (Xie and Du, 2011), antioxidant (Argüello-García et al., 2010; Elosta et al., 2017), anticancer (Petrovic et al., 2018), lipid-lowering (Brandolini et al., 2005), antihypertensive (Liperoti et al., 2017), antiatherogenic (Brown et al., 2015) and cardioprotective role (Bouillaud and Blachier, 2011). Studies have confirmed that garlic plays a role in preventive effects in cardiovascular and cerebrovascular diseases, tumors, diabetes, and others (Cavallito and Bailey, 1944). Some people have difficulty accepting garlic’s pungent and irritating taste but wish to consume garlic for long-term disease prevention and health care. Therefore, garlic products are innovated, and products such as garlic lyophilized powder, allicin, and garlic extract have been developed (Li et al., 2017).

Chemical composition of garlic

More than 80 monomer compounds have been identified in garlic, mainly divided into volatile and nonvolatile compounds (Figures 3, 4).

FIGURE 3.

FIGURE 3

The representative sulfur compounds of garlic.

FIGURE 4.

FIGURE 4

Other compounds of garlic.

Volatile compounds

Volatile compounds in garlic include sulfur-containing compounds such as lipid-soluble organic sulfides and thiosulfinate (Hu et al., 2019). There are more than 30 kinds of sulfur-containing components in garlic, which is the primary bioactive substance of garlic. The main sulfur-containing compounds in garlic are alliin, allicin, etc. Alliin, chemically named S-Allyl-l-cysteine Sulfoxide (SACS), is an essential sulfur-containing compound in garlic bulbs. The most abundant sulfur-containing amino acid in garlic exists in the cytoplasm of garlic bulb cells (Almatroodi et al., 2019). Alliin inhibits platelet aggregation and may reduce the incidence of AS (Eric, 1985). Sheela et al. found that Alliin effectively reversed the elevation of lipids and lipid peroxides in hypercholesterolemic rats (Kendler, 1987). Alliinase and allinase are endogenous enzymes in garlic. Allinase, also known as Alliin lyase, is a dimeric glycoprotein in the vacuole of garlic scale bud cells and is more sensitive to temperature (Weiner et al., 2009). Allinase activity decreases when garlic is heated and vinegared.

Studies have shown that garlic has played a significant role in medicinal and edible due to the various thiosulfinate. The primary efficacy component is diallyl thiosulfinate (allicin) (Cavallito and Bailey, 1944). Thiosulfinate can inhibit the growth and reproduction of many germs and achieve better roles in anti-inflammatory and sterilizing. It also has antitumor (Bat-Chen et al., 2010), antioxidant (Ilić et al., 2015), lipid-lowering (Elkayam et al., 2013), and glucose-lowering (Arellano-Buendía et al., 2020) effects. After garlic is cut or crushed, alliin contained in the cell meets allinase and splits to produce allicin (Lanzotti, 2006). Allicin is unstable due to its sulfoxide and allyl structure and can be decomposed in a few hours at room temperature in the air. Allicin is the main component of fresh garlic homogenate (Salehi et al., 2019). Allicin can be further decomposed to produce the more stable ajone, dallyl sulfide (DAS), dallyl disulfide (DADS), and a small amount of dallyl trisulfide (DATS), dallyl Tetrasulfide (DATTS), which is the main component of new garlic oil extracted by steam distillation (Cao and Chen, 2008).

Since allicin is unstable, it cannot be prepared directly for use as a medicine. Allicin’s production rate is low because gastric acid inactivates allinase when consuming raw garlic. Therefore, to ensure the stability of the active ingredients of garlic, low-temperature extraction, microwave inactivation, chromatographic separation, ultrafiltration purification, spray drying, and other methods are often used to prepare new garlic preparations with high efficiency. At present, most companies at home and abroad make lyophilized garlic powder and enteric formulations of lyophilized garlic powder to improve the production rate of allicin in vivo (Yang et al., 2021).

DATS is known as a natural broad-spectrum antibiotic. DATS crosses the blood-brain barrier, scavenges free radicals, and achieves antioxidant effects by reducing the production of reactive oxygen species (Yan and Zeng, 2004). DATS has anti-mutagenic and anti-carcinogenic effects (Hong et al., 1992). Methyl allyl trisulfide (MATS) is the most substantial antifungal component in essential garlic oil, which can inhibit platelet aggregation and prevent thromboxane synthesis (Ariga et al., 1981). Ajone was reported as an active substance with a solid antiplatelet aggregation effect (Block, 1985, 1986). Ajone plays an essential role in cell-mediated immunity, humoral immune regulation, and other processes (Lawson et al., 1991).

Nonvolatile compounds

Another class of compounds in garlic is nonvolatile compounds, mainly including water-soluble organic sulfides, steroidal saponins, saponin elements, flavonoids, phenols, peptides, enzymes, and organoselenium, organogermanium, hemagglutinin, fructans, prostaglandins, etc.

Up to now, 20 saponins have been extracted, isolated, and identified from garlic (Matsuura, 2001). Two new steroidal saponins were isolated from the water-soluble fraction of garlic, one was Proto-iso-eruboside B, and the other was iso-eruboside B. In addition, there were eruboside B and Sativoside C. Further, Sativoside -B2, -B3, -B4, and -B5 could be isolated from eruboside-B (Peng et al., 1996). Spirostanol saponin and Furostanol saponin are the main saponin components of garlic, and both saponins have hypolipidemic, antibacterial, and antitumor effects (Yan and Zeng, 2004). Garlic saponin can significantly inhibit platelet aggregation and prolong blood coagulation time to prevent and delay thrombosis.

Additionally, it can promote fibrinolysis (Peng et al., 1996). Garlic polysaccharide is one of the active ingredients with high content in garlic, accounting for 51% of the dry weight of garlic. Garlic polysaccharide with higher concentration has a more vital scavenging ability for free radicals (Lee et al., 2015). Six flavonoids and two polyphenols have been isolated from garlic, including apigenin, kaempferol, quercetin, luteolin, and N-ferulic acid-based tyramine.

In addition, in garlic, proteins, vitamins, fatty acids, biotin, nicotinic acid, and rare elements such as selenium and germanium have prominent pharmacological activities, such as antibacterial and anti-inflammatory, and cholesterol reduction.

The pharmacological activity of garlic

Hypolipidemic

Lipid migration is essential in developing AS (Wu et al., 2018). Oxidative modification of LDL induces phagocytosis and conversion of macrophages to foam cells (Wang H et al., 2017; Sharifi et al., 2019). Lecithin cholesterol acyltransferase (LCAT) catalyzes the esterification of free cholesterol, which promotes the maturation of high-density lipoprotein (HDL) and the reverse transport of cholesterol. Lipoprotein lipase (LPL) is the main enzyme in plasma that catalyzes the esterification of triglyceride-rich lipoproteins. Hepatic lipase (HL) can encourage the liver to take up and remove triglyceride-rich lipoprotein residues. The increased activity of these enzymes will stimulate the metabolism and transformation of lipids and reduce the level of blood lipids.

Kwak et al. (2014) found a reduction in serum total cholesterol (TC) levels in patients with hypercholesterolemia after taking garlic powder by Meta-analysis. Matsumoto et al. (2016) conducted a prospective randomized, double-blind trial of garlic extract for metabolic syndrome. They found that plaque reduction was significantly more significant in the AGE group than in a placebo group and that AGE also could stabilize vulnerable plaque. A meta-analysis of garlic modulation of serum TC conducted by Ried (2016) showed that garlic effectively reduced TC and Low-Density Lipoprotein Cholesterol (LDL-C) concentrations and increased macrophage activity and T and B cell production, with immunomodulatory effects.

Garlic oil could reduce TC and Triglyceride (TG) concentrations in hyperlipidemic mice, probably by promoting the metabolism and conversion of lipoproteins, or inhibiting intestinal cholesterol absorption, slowing down hepatic cholesterol synthesis, and thus accelerating TG breakdown (Zhang et al., 2007; Meng et al., 2016). The expression of Scavenger receptor class A (SR-A) and the cluster of differentiation 36 (CD36) directly affects the lipid deposition in macrophages and has an essential impact on macrophage foaminess (Twigg et al., 2012). C-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) of mitogen-activated protein kinase (MAPK) pathway are critical signal pathways for regulating scavenger receptors and AS (Nikolic et al., 2011). JNK has been reported to regulate AS by regulating scavenger receptor expression, and JNK knockdown macrophages inhibit lipid uptake and foam formation (Sumara et al., 2005; de Nigris et al., 2012). Allicin could significantly inhibit the activation of JNK and p38 MAPK and down-regulate the increase of SR-A and CD36 expression, suggesting that allicin affects macrophage foam formation by regulating the expression of scavenger receptors (Wang L et al., 2017). Allicin promotes cholesterol efflux through upregulation of ATP Binding Cassette Subfamily A Member 1 (ABCA1). It reduces lipid accumulation in THP-1 macrophage-derived foam cells by activating Peroxisome proliferator-activated receptor Gamma (PPARγ)/Liver X receptor α (LXRα) signaling (Lin et al., 2017).

Inhibition of cholesterol synthesis by S-allyl cysteine (SAC), S-ethyl cysteine (SEC), and S-propyl cysteine (SPC) was achieved by inhibiting the activity of hydroxy-3-methyl glutaryl coenzyme A reductase (HMGCR) (Liu and Yeh, 2002). N-acetylcysteine (NAC), SEC, and SPC reduce TG and TC accumulation in the liver by a mechanism associated with the reduction of sterol regulatory element-binding protein-1c (SREBP-1c), sterol regulatory element-binding protein-2 (SREBP-2) (Lin and Yin, 2008). DADS inhibits hepatic TG and relates lipid synthesis by downregulating SREBP-1c expression. In addition, DADS can accelerate TG catabolism and fatty acid oxidative metabolism by upregulating the expression of peroxisome proliferator-activated receptor α (PPARα) in hepatocytes (Wang et al., 2019). SAC activates AMP-activated protein kinase (AMPK) through calcium/calmodulin-dependent kinase (CaMKK), silent information regulator T1, and inhibits sterol regulatory element-binding proteins-1 (SREBP-1)-mediated hepatic adipogenesis (Hwang et al., 2013). Allicin was found to enhance the activity of serum LCAT, LPL, and HL, thereby reducing plasma TG and TC levels (Zhang et al., 2007).

Microsomal triglyceride transfer protein (MTP) is the rate-limiting factor for VLDL apoB secretion. MTP plays an essential role in regulating lipoprotein production in the liver and intestine. Inhibition of MTP activity has been shown to decrease the rate of secretion of apoB-containing lipoproteins in HepG2 cells (Jamil et al., 1996) and intestinal Caco-2 cells (van Greevenbroek et al., 1998) in vitro. Fresh garlic extract (FGE) inhibits the synthesis and secretion of intestinal chylomicrons by suppressing the expression of microsomal MTP genes for lipid-lowering (Lin et al., 2002). Acyl-CoA: cholesterol acyltransferase (ACAT) is the rate-limiting enzyme that catalyzes the formation of cholesteryl esters by linking cholesterol with long-chain fatty acids (Yao et al., 2006). Garlic powder extract (GPE) was able to inhibit the activity of ACAT and enhance the activity of Cholesteryl ester hydrolase (CEH) (Orekhov and Tertov, 1997), thus significantly reducing the accumulation of intracellular cholesteryl esters.

Antioxidant

Oxidative stress (OS) is mainly caused by the increase of reactive oxygen species (ROS) and reactive nitrogen species (RNS), which can lead to endothelial remodeling, tissue damage, and eventually AS (Canugovi et al., 2019). In endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and macrophages, mitochondrial dysfunction and nicotinamide adenine dinucleotide phosphate oxidase (NOX) can cause excessive ROS production in vivo and accelerate the development of AS by causing the impaired function of ECs, proliferation, and migration of VSMCs, macrophage foaminess and inflammatory response through various pathways.

A meta-analysis shows that garlic supplementation improves antioxidant status by increasing total antioxidant capacity (T-AOC) and decreasing Malondialdehyde (MDA) levels (Moosavian et al., 2020). SAC inhibits Oxidized Low-Density Lipoprotein (ox-LDL) (Ide and Lau, 2001), inducible nitric oxide synthase (iNOS) activity (Kim et al., 2001), peroxides production, and prevents intracellular glutathione (GSH) depletion in ECs. In addition, it has been shown that garlic polysaccharides can reduce MDA, Nitric Oxide (NO) levels in serum and inhibit lipid peroxidation in mice (Li et al., 2003). DADS activates the Kelch Like ECH Associated Protein 1 (Keap1)/nuclear erythroid 2-related factor 2 (Nrf2) pathway and upregulates NAD. (P)H: quinone oxidoreductase 1 (NQO1), γ-glutamylcysteine synthetase antibody (γ-GCSc), and Superoxide Dismutase 1 (SOD-1) expression levels, and improves hepatic oxidative stress levels in high-fat-fed Wistar rats (Wang et al., 2019). The up-regulation of Sirtuin 1 (SIRT1) activity can reduce ROS production in endothelial cells, thus protecting vascular endothelial cells from ROS damage (Wu et al., 2014). Allicin can promote the phosphorylation of SIRT1, upregulate the activity of SIRT1, and reduce the production of ROS and the expression of plasma activator inhibitor-1 (PAI-1) in cells (Suo et al., 2013; Hu et al., 2016). Garlic sulfide can regulate mitochondrial respiration in cardiac myocytes and produce hydrogen sulfide via myocardial mitochondria, which can diastole contracted vascular smooth muscle (Li et al., 2016) and play the anti-myocardial ischemic effect. Total saponins of garlic (TSG) exerted antioxidant effects by inhibiting MDA content and restoring reduced superoxide dismutase (SOD) activity (Miao et al., 2020). Activation of ox-LDL and nuclear factor kappa-B (NF-κB) is associated with AS, and SAC inhibits ox-LDL activation in macrophages and human umbilical vein endothelial cells (HUVECs) of J774 mice with dose-dependent inhibition of NF-κB activation. It indicated that SAC could slow the progression of AS by inhibiting ox-LDL and interfering with the cascade of oxidative signaling (Ho et al., 2001). Treatment of New Zealand rabbits receiving a high-cholesterol diet with allicin significantly reduces MDA while increasing GSH and SOD levels (El-Sheakh et al., 2016). The antiatherogenic effect of allicin may be related to its ability to scavenge free radicals and restore antioxidant defense systems.

Antithrombotic

During plaque formation, changes in hemodynamics increase plaque instability and can easily lead to plaque rupture. Once the plaque ruptures, platelet activation in the blood, activation of the coagulation pathway cascade, and multicellular mobilization lead to platelet-rich emboli that block blood vessels and cause malignant clinical events such as ischemic myocardial infarction and stroke (Kobiyama and Ley, 2018). Antithrombotic therapy is an essential part of the treatment of patients with AS. Activated platelets mediate plaque instability involved in chronic AS development by releasing large amounts of inflammatory secretions and expressing multiple membrane immune receptors interacting with different leukocyte subpopulations and endothelial cells (Siegel-Axel et al., 2008; Peter Seizer, 2008; Li et al., 2011).

Possible mechanisms for the antithrombotic activity of garlic include: inhibiting the secretion of Cyclooxygenase-1 (COX1), reducing the synthesis of Thromboxane B2 (TXB2), reducing the secretion of Leukotriene C4 (LTC4C4C) and Prostaglandin E2 (PGE2) (Bordia et al., 1996), reducing the release of arachidonic acid (AA) (Mohammad and Woodward, 1986) from phospholipids, upregulating 5-hydroxy tryptamine (5-HT) and inhibiting the release of coagulation factor IV from platelets (Makheja and Bailey, 1990). Garlic effectively inhibits platelet aggregation induced by the calcium ion aggregate A23187. Therefore, the antiplatelet aggregation effect of garlic may be related to the mobilization of calcium within platelets (Srivastava, 1986).

A double-blind placebo-controlled randomized study showed that treating patients with cerebral atherosclerosis with garlic powder pills (Allicor) for 14 days resulted in a 25% reduction in ADP-induced platelet aggregation and a 22% upregulation in plasma fibrinolytic activity (Sobenin et al., 2010). However, a randomized, double-blind placebo-controlled crossover study showed that garlic oil caused a significant 12% reduction in epinephrine-induced platelet aggregation but had no effect on collagen-induced or ADP-induced platelet aggregation (Wojcikowski et al., 2007). This contradiction suggests that garlic may inhibit platelet aggregation through multiple mechanisms. Clinical studies have confirmed that processed garlic improves the potency and bioavailability of organosulfides and is more likely to exert antithrombotic effects than raw garlic (Lawson and Gardner, 2005). A randomized controlled trial confirmed that garlic oil significantly increased fibrinolytic activity. The standard components of garlic oil, DADS and DATS, inhibited platelet agonist-induced platelet aggregation (PAg) and platelet thromboxane formation (Bordia et al., 1998).

TXB2 and prostaglandin I2 (PGI2) are metabolites of AA. Thromboxane A2 (TXA2) induces vasoconstriction and platelet aggregation and promotes AS formation. In contrast, PGI2 has the function of vasodilation and inhibiting platelet aggregation. The TXA2 and PGI2 are usually determined by measuring their stable metabolites TXB2 and 6-keto-prostaglandin F1α (6-keto-PGF1α). Total saponins of garlic (TSG) reduces the level of TXB2 and increases the level of 6-keto-PGF1α, and the ratio of TXB2 to 6-keto-PGF1α is maintained in a relatively stable dynamic equilibrium to maintain vascular homeostasis (Miao et al., 2020). α-Granules and dense granules enhanced the conduction pathway of platelet activation. A rapid release of ATP characterizes the early phase of platelet activation. Fermented and non-fermented garlic products inhibit ATP release from dense granules and exert antiplatelet effects by inhibiting platelet granule secretion (Irfan et al., 2019). Adhesion molecules such as Vascular Cell Adhesion Molecule 1 (VCAM-1) and intercellular cell adhesion molecule-1 (ICAM-1) promote platelet adhesion and leukocyte recruitment and play an essential role in AS formation (Kim et al., 2018). Garlic powder decreased VCAM-1and ICAM-1 level, significantly increasing activated partial thromboplasting time (APTT). It indicated that garlic might contribute to treating AS by delaying clotting time, altering angiotensin, and decreasing the expression of VCAM-1 and ICAM-1.

Tissue factor (TF) is a crucial factor in initiating the extrinsic coagulation cascade pathway, which is responsible for producing thrombin from prothrombin via activation of factor VII (Dahlbäck, 2000). Subendothelial TF is also accountable for initiating fibrin formation at sites of vascular injury, and blood-borne TF may be a vital contributor to the propagation of the developing thrombus (Grover and Mackman, 2020). It has been reported that tumor necrosis factor-α (TNF-α) induced TF mRNA expression in HUVECs was suppressed by the inhibition of JNK. Therefore, inhibition of the JNK pathway by DATS may inhibit the induction of TF by TNF-α. DATS inhibited not only TF activity but also TF mRNA and protein expression in vitro (Okue et al., 2022). Garlic is a promising food with anti-thrombotic function, which can suppress both primary and secondary clot formation. The antithrombotic effect of garlic is beneficial for patients who are allergic or intolerant to aspirin and is expected to be an alternative or complementary therapy to antiplatelet therapy.

Inhibit angiogenesis

Plaque angiogenesis is considered to play an essential role in the pathophysiological development of AS. Neointimal angiogenesis is highly related to plaque formation and the risk of plaque rupture. Plaque angiogenesis quickly leads to the formation of plaque and thus increasing the risk of rupture (Sluimer and Daemen, 2009). In the past 30 years, the research mainly focused on the role of new blood vessels in plaque formation and rupture (Kockx et al., 2003; Sluimer et al., 2009), which revealed that there was an expanding network of new blood vessels in plaque in the stenosis near the inflammatory infiltration and necrotic core. Plaque angiogenesis is related to plaque vulnerability and plaque erosion. Many angiogenic factors participate in plaque formation, mainly vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF).

Akt activation is associated with angiogenesis (Morales-Ruiz et al., 2000). In vitro and in vitro experiments proved that Allicin can inhibit angiogenesis and weaken epithelial cell proliferation, tubule formation, actin polymerization, and Akt phosphorylation by reducing VEGF and bFGF expression (Sela et al., 2008). DATS is an effective inhibitor of the angiogenic properties of HUVECs in vitro, for example, inhabiting capillary tube formation and migration. It is related to caspase-dependent induction of apoptosis, inhibition of VEGF secretion, inactivation of vascular endothelial growth factor receptor 2 (VEGF-R2) and Akt kinase, and activation of extracellular regulated protein kinases (ERK1/2) (Xiao et al., 2006).

Endothelium protection

ECs dysfunction is a crucial factor in the development of AS (Donato et al., 2018). The dysfunction of ECs refers to a decrease in NO-mediated vasodilatory responses in ECs in response to different pathological stimuli. The excessive synthesis of Endothelin-1 (ET1) leads to an increase in vasoconstriction and vascular permeability. This change can lead to the release of pro-inflammatory factors, over-activation of platelets, enhanced oxidation of LDL, and proliferation and migration of vascular smooth muscle cells (Gimbrone and García-Cardeña, 2016; Pi et al., 2018).

Clinical studies have found that allicin reduces ET-1 and C-reaction protein (CRP) levels and elevates NO levels, improves endothelial dysfunction, and reduces the incidence of restenosis in patients after PCI (Wang and Fu, 2009). In patients with coronary artery disease combined with diabetes, oral administration of allicin capsules resulted in a significant improvement in flow-mediated dilation (FMD) and NO levels, and a decline in ICAM-1 level and incidence of major adverse cardiovascular events in the allicin group compared to the control group, which may be related to allicin’s improvement in endothelial function (Nie et al., 2013). A randomized, placebo-controlled, crossover trial suggested that short-term treatment with AGE may improve endothelial function in patients with coronary artery heart disease (CHD) (Williams et al., 2005). Another randomized, double-blind, placebo-controlled trial found that AGE supplementation was beneficial in reducing endothelial biomarkers associated with cardiovascular risks, such as the arterial stiffness index (SI), high-sensitivity C-reactive protein (hsCRP), PAI-1 as well as total antioxidant status (TAS) (Szulińska et al., 2018).

The adhesion of leukocytes/monocytes to endothelium is an early event of AS. Garlic extracts significantly reduce the expression of ICAM-1 and VCAM-1 induced by Interleukin-1 alpha (IL-1a) and considerably inhibit the adhesion of monocytes to endothelial cells stimulated by IL-1a (Rassoul et al., 2006). l-arginine in AGE promotes NO production mediated by Endothelin nitric oxide synthase (eNOS), leading to vasodilation (Nie et al., 2002; Takashima et al., 2017). Oral DADS analogs can reverse L-N G-Nitro arginine methyl ester (l-NAME)-induced systolic blood pressure, oxidative stress, Angiotensin Converting Enzyme (ACE) activity, cyclic guanosine monophosphate (cGMP), and NO levels, which may be related to activation of eNOS (Williams et al., 2005). DAT significantly reduced the levels of MDA and ROS in mitochondria and increased the activities of SOD and Glutathione peroxidase (GSH-Px). DAT protects the vascular endothelium from hyperglycemia-induced damage by reducing oxidative stress in mitochondria (Liu et al., 2014). The calcium-sensing receptor (CaSR) is a member of the G protein-coupled receptor superfamily, and activation of CaSR reduces cell viability and promotes apoptosis (Zhang et al., 2020). Allicin may inhibit cardiomyocyte apoptosis and protect vascular endothelial function by suppressing the expression of CaSR and inhibiting the oxidative stress response (Xu et al., 2020). This suggests that garlic consumption may reduce oxidative damage to endothelial cells and improve vascular function.

Vascular endothelial barrier function is maintained by a cell-to-cell junctional proteins and contributes to vascular homeostasis (Chistiakov et al., 2015). Various risk factors such as inflammation disrupt barrier function through down-regulation of these proteins and promote vascular diseases such as atherosclerosis (Hofmann et al., 2002).

AGE and its primary sulfur-containing constituent, S-1-propenylcysteine (S1PC), reduced hyperpermeability elicited by TNF-α in HUVECs. In addition, S1PC inhibited TNF-α-induced production of myosin light chain (MLC) kinase and inactivation of MLC phosphatase through the suppression of the Rac and Ras homolog gene family, member A (RhoA) signaling pathways, respectively, which resulted in the dephosphorylation of MLC2, a key factor of actin remodeling. Moreover, S1PC inhibited the phosphorylation and activation of guanine nucleotide exchange factor-H1 (GEF-H1), a common upstream key molecule and activator of Rac and RhoA. These effects of S1PC were accompanied by its ability to prevent the disruption of junctional proteins in the cell-cell contact regions and the increase of actin stress fibers induced by TNF-α (Kunimura et al., 2021). The study suggested that AGE and S1PC improve endothelial barrier disruption by inhibiting the GEF-H1/RhoA/Rac pathway.

Anti-inflammatory

It is generally known that AS is considered a chronic inflammatory disease because inflammation goes through all AS processes and plays an essential role. When ECs are activated, Inflammatory factors such as monocyte chemotactic protein 1 (MCP-1), interleukin-8 (IL-8), ICAM-1, VCAM-1, Endothelial leukocyte adhesion molecule-1 (ELAM-1), and granular membrane protein 140 (GMP140) attract lymphocytes and monocytes bound to ECs and arterial walls, contributing to inflammation (Zhu et al., 2018). In addition, monocytes differentiate into macrophages which can phagocytize ox-LDL and ultimately transform it into lipid-laden foam cells (Kattoor et al., 2019; Javadifar et al., 2021). During arterial endothelium damage, foam cells form and accumulate and release inflammatory mediators such as MCP-1 and TNF-α (Javadifar et al., 2021). The activation of the NF-κB signaling pathway stimulates the formation of the inflammatory process, which leads ECs to take on AS phenotypes in the carotid sinus (Tabas et al., 2015). In a randomized, double-blind placebo-controlled trial by Martiné Wlosinska et al., 104 AS patients took 2400 mg AGE capsules daily for 12 months. The results showed that AGE could effectively decrease levels of IL-6 (Wlosinska et al., 2020). AGE’s anti-atherosclerosis effects include reducing CRP and TXB2, down-regulating TNF-α and interleukin-1 receptor-activated kinase 4 (IRAK4) productions, and increasing AMPK activity in the liver (Morihara et al., 2017). AGE also regulates the inflammatory process by inducing AMPK activation and down-regulating the Toll-like receptor (TLR) signaling pathway (Miki et al., 2017). Z-Ajone reduces the phosphorylation and nuclear translocation of STAT3, inhibits the activity of Cyclooxygenase-2 (COX2) (Hitchcock et al., 2021), and carries out S-sulfhydrylation of cysteine sulfhydryl groups in two inflammatory proteins, thus producing downstream anti-inflammatory effects.

The innate and adaptive immunity cells play a significant role in atherosclerosis progression. Dynamic change in blood lipid levels could trigger CD4+ T-cells to differentiate into effector cells and produce cytokine during atherogenesis (Tabas and Lichtman, 2017). T helper 1 cell (Th1) is the subset of T lymphocytes mostly found in atherosclerotic lesions based on the cytokine it produces. Th1 cells secrete Interferon-gamma (IFN-g) and TNF-a proinflammatory cytokines to enhance immune response through macrophage activation, smooth muscle cells, and endothelial cells during atherogenesis (Wu et al., 2017). A study confirmed that Single garlic oil could suppress CD4 t-cells activation and NF-κB expression in high-fat diet mice. Furthermore, Single garlic oil plays a role as an athero-protective agent in the High-fat diet condition through the decrease in proinflammatory cytokines such as TNF-a and IFN-g (Lestari et al., 2020). SGO could act as a promising prospect for therapy to improve chronic inflammation in AS.

It has been reported that the development of atherosclerosis alters the ratio of polarized macrophages. M1 macrophages promote the formation of AS plaques by sustaining inflammation, whereas M2 macrophages aid the regression of atherosclerotic (Yang et al., 2020). AGE increased the mRNA or protein levels of arginase1 (Arg1), interleukin-10 (IL-10), CD206, and hypoxia-inducible factor 2α (HIF2α). It decreased that of CD68, HIF1α, and inducible NO synthase in the aorta and spleen of Apo E−/− mice. S1PC increased the level of IL-10-induced Arg1 mRNA and the extent of M2c-like macrophage polarization in vitro. In addition, S1PC increased the population of M2c-like macrophages, suppressing the people of M1-like macrophages and decreasing lipopolysaccharide-induced production of pro-inflammatory cytokines. These effects were accompanied by prolonged phosphorylation of the IL-10 receptor α (IL-10Rα) and signal transducer and activator of transcription 3 (STAT3) that inhibited the interaction between IL-10Rα and Src homology-2-containing inositol 5′-phosphatase 1 (SHIP1) (Miki et al., 2021). These findings suggest that S1PC may help improve atherosclerosis due to its anti-inflammatory effect in promoting IL-10-induced M2c macrophage polarization.

Anti-apoptotic

Cell proliferation and apoptosis rates are key indicators of cell viability and apoptosis, further aggravating atherosclerotic plaque’s progression and instability. Allicin significantly increased the cell viability of HUVECs, inhibited apoptosis, and protected against ox-LDL-induced damage in HUVECs by inhibiting caspase-3 and Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-related apoptotic signaling pathways (Chen et al., 2016).

H2O2 can cause apoptosis in vascular ECs through multiple pathways and is recognized as a standard model of oxidative injury. Allicin effectively reduced H2O2-induced apoptosis in HUVECs, probably because allicin stabilized the expression of pro-Caspase-3 protein and decreased the expression of poly adenosine diphosphate-ribose polymerase (PARP) and BCL2-Associated X (Bax) proteins. Allicin can increase SOD, NO, and eNOS and decrease MDA, indicating that allicin can protect HUVECs induced by H2O2 from apoptosis by reducing oxidative stress (Chen et al., 2014).

Allicin can attenuate apoptosis induced by Lipopolysaccharide (LPS), and its mechanism is related to inhibition of mitochondrial dysfunction, such as inhibition of matrix metalloproteinases (MMPs) collapse, reduction of cytochrome c synthesis, and mitochondrial ATP release (Zhang et al., 2017). Cardiomyocyte apoptosis plays a vital role in the development of AS. High cholesterol diet-induced apoptosis in cardiomyocytes is associated with Fatty acid synthase (Fas)-dependent and mitochondria-dependent apoptotic pathway activity. Mitochondrial-dependent pathway plays an essential role in cell apoptosis by releasing caspase 9. Garlic activates the PI3K-Akt pathway, inhibits TNF-α, Fas, caspase 8, caspase 9, and caspase 3, upregulates the protein level of mitochondrial B-cell lymphoma-2 (Bcl-2), and reduces the protein levels of recombinant human bh3-interacting domain death agonist (B.I.D.) and Bax (Cheng et al., 2013), thus inhibiting myocardial cell apoptosis.

Other antiatherogenic mechanisms

In addition to the above mechanisms, garlic and its extracts can also inhibit the development of AS by inhibiting the proliferation of vascular smooth muscle, regulating gut microbiota and supplement with phytoestrogens.

An essential feature of AS is the transformation of quiescent or differentiated VSMCs into proliferating or dedifferentiated cells, leading to enhanced migration of VSMCs. Ajoene and MATS down-regulate the activities of protein farnesyltransferase (PFTase) and protein geranylgeranyltransferase type I (PGGTase-I), contributing to the inhibition of VSMCs proliferation (Ferri et al., 2003; Golovchenko et al., 2003). AGE reduced aortic fatty streaks and carotid intima-media thickness in cholesterol-fed New Zealand rabbits and acted by reducing tissue cholesterol accumulation and inhibiting smooth muscle proliferation. Thus, AGE may protect against the development of AS (Efendy et al., 1997).

AS is strongly associated with the gut microbiota and its metabolites. A study confirmed that certain beneficial and anti-inflammatory gut commensal bacteria, including Faecalibacterium prausnitzii and Akkermansia spp., were significantly enriched after the 1-week allicin intervention in High-TMAO patients (Panyod et al., 2022). In diet-induced obese (DIO) mice alliin regulates glucose metabolism by reducing Lachnospiraceae and increasing Ruminococcaceae in the intestine, thereby delaying the progression of AS (Zhai et al., 2018). Garlic may be an essential prebiotic, which can induce the growth of beneficial flora (The cardiovascular effects are shown in Table 1 and Figure 5).

TABLE 1.

Major effects and targets of garlic in atherosclerosis.

Effects Materials or bioactive compound Species/exposure subjects Targets Dose/concentration (route of administration) Duration Adverse effect Reference
Hypolipidemic Allicin High-fat diet-induced Apo E−/− mices (6 w) and peritoneal macrophage SR-A↓ 10, 20 mg/kg/d (i.g., n = 10) 12 w N Wang H et al. (2017)
CD36↓
JNK↓
P38 MAPK↓
NAC High-fat diet-induced C57BL/6 mices (3—4 w) SREBP-1c↓ 1 g/L (i.g., n = 15) 4 w N Lin and Yin, (2008)
SEC SREBP-2↓
SPC
SAC FFA mixture induced HepG2 cells AMPK↑ 0.5–10 mM 24 h N Hwang et al. (2013)
SREBP-1↓
Allicin Ox-LDL induced THP-1 macrophage-derived foam cells ABCA1 ↑ 2.5, 5, 10, 20 and 40 g/L 3, 6, 12, 24, 48 h N Lin et al. (2017)
PPARγ/LXRα ↑
Allicin High-fat diet-induced Kunming mices (20 ± 2 g) LCAT↑ 1, 2, 3 mg/kg/d (i.g., n = 10) 10 days N Zhang et al. (2007)
LPL↑
HL↑
HMGCR↓
FGE HepG2 MTP↓ 3, 6, 5 g/kg·bw (i.g., n = 6) 3, 6 h N Lin et al. (2002)
Caco-2 cells
Male SD rats (190–210 g)
GPE Human aortic subendothelial intimal smooth muscle cells from men who died of myocardial infarction ACAT↓ allicin (3.58 mmol/L) and ajoene (0.184 mmol/L) 24 h N Orekhov and Tertov, (1997)
CEH↑
DADS High-fat diet-induced Wistar rats (200 ± 20 g) SREBP-1c↓ 15, 30, 60 mg/kg·bw (i.g., n = 10) 5 w N Wang et al. (2019)
PPAR-α↑
Antioxidant DADS High-fat diet-induced Wistar rats (200 ± 20 g) Keap1/Nrf2↑ 15, 30, 60 mg/kg·bw (i.g., n = 10) 5 w N Wang et al. (2019)
NQO1↑
γ-GCSc↑
SOD-1↑
Allicin H2O2 induced HUVECs SIRT1↑ 5 ng/ml 24 h N Hu et al. (2016)
ROS↓
PAI-1↓
TSG Combination of high-fat feeding, intraperitoneal injection of vitamin D3, and ovalbumin-induced inflammation in SD rats (200 ± 20 g) MDA↓ 0.6, 1.2, 2.4 g/kg/d (i.g., n = 12) 4 w N Miao et al. (2020)
SOD↑
SAC HUVECs and murine J774 macrophage cell line stimulated with ox-LDL ROS↓ 0,2.5,5,10,20 mM 1, 2, 3 h N Ho et al. (2001)
NF-κB↓
Allicin High cholesterol diet-induced male New Zealand rabbits (1.30 ± 0.40 kg) MDA↓ 10 mg/kg/d (po, n = 8) 4 w N El-Sheakh et al. (2016)
SOD↑
GSH↑
Antithrombotic TSG. Combination of high-fat feeding, intraperitoneal injection of vitamin D3, and ovalbumin-induced inflammation in SD rats (200 ± 20 g) TXB2↓ 0.6, 1.2, 2.4 g/kg/d (i.g., n = 12) 4 w N Miao et al. (2020)
6-keto-PGF1α↑
Fermented garlic Hypercholesterolemic diet-induced SD rats (180–200 g) α-granules↓ 300 mg/kg/d (po, n = 5) 30 days N Irfan et al. (2019)
Dense granules↓
Garlic powder Saline, collagen, and epinephrine induced SD rats (5 w) VCAM-1↓ 500 mg/kg·bw (i.g., n = 8) 7 days N Kim et al. (2018)
ICAM-1↓
DATS TNF-α stimulated HUVECs JNK↓ 50 or 100 μm 30 min N Okue et al. (2022)
TF↓
Inhibit angiogenesis DATS VEGF induced HUVECs VEGF↓ 5, 10, 20 μm 24, 48, 72 h N Xiao et al. (2006)
VEGFR2↓
Akt ↓
ERK1/2 ↑
Allicin Type I collagen-induced rat aorta ring VEGF↓ 0.2, 0.5, 1 m 6 days N Sela et al. (2008)
bFGF↓
Allicin Bovine aortic endothelial cells VEGF↓ 0.1, 0.2, 0.5, 1, 10 mm, 24 h N Sela et al. (2008)
bFGF↓
Akt ↓
Endothelium Protection Allicin capsule Elderly myocardial infarction patients (57.86 ± 11.20 a) ET-1↓ 120 mg/d (po., n = 75) 1 a N Wang and Fu, (2009)
CRP↓
NO↑
ASE IL-1a induced HCAECs ICAM-1↓ 0.25–4.0 mg/ml 4 days N Rassoul et al. (2006)
Monocytic U937 cell line VCAM-1↓
Allicin capsule Patients with coronary heart disease combined with diabetes (61 ± 11 a) NO↑ 120 mg/d (po., n = 60) 90 days N Nie et al. (2013)
ICAM-1↓
AGE Endothelium-denuded aortic rings eNOS↑ 0.5% (w/v) 10 min N Takashima et al. (2017)
NO↑
Allicin Patients with angina pectoris (60.8 ± 10.7 a) eNOS↑ 60 mg/d (po., n = 43) 10 days N Nie et al. (2002)
NO↑
DAT. High glucose-induced HUVECs MDA↓ 25, 50, 100 mmol/L 24 h N Liu et al. (2014)
ROS↓
SOD↑
GSH-Px↑
Allicin High-fat diet induced SD rats (220—250 g) CaSR↓ 20 mg/kg/d (i.g., n = 12) 14 days N Xu et al. (2020)
S1PC TNF-α Induced HUVECs GEF-H1/RhoA/Rac↓ 75–300 μM 10, 15, 20, 30, 40 min, 1, 3 or 24 h N Kunimura et al. (2021)
SAC MLC kinase↓ 300 μM
SAMC 300 μM
Anti-Inflammatory AGE CE-2 diet-induced ApoE-KO mices (5 w) CRP↓ Liquid AGE was mixed with CE-2 to make the solid content of AGE to 3% (po) 12 w N Morihara et al. (2017)
TXB2↓
TNF-α↓
IRAK4↓
AMPK↑
AGE. CE-2 diet-induced TSOD mices (4 w) AMPK↑ the CE-2 diet containing 2% (w/w) AGE (po) 19 w N Miki et al. (2017)
TLR signal path↓
Z-ajoene L.P.S. induced RAW264.7 STAT3↓ 10 μL 24 h N Hitchcock et al. (2021)
COX2↓
IL1β↓
IL6↓
IL12β↓
IL10↑
Single garlic oil High-fat diet-induced Balb/C mices (38 ± 5 g) CD4 t-cells↓ NF-κB↓ 12.5, 25, 50 mg/kg·bw/d (po., n = 4) 4 w N Lestari et al. (2020)
TNF-a↓
IFN-g↓
AGE C57BL/6 J, Apo E−/− mices (6 w) Arg1↑ Standard diets with or with 3% AGE (po., n = 5–8) 17 w N Miki et al. (2021)
IL-10↑
CD206↑
HIF2α↑
CD68↓
HIF1α↓
IL-10rα
STAT3
SHIP1↓
Anti-apoptotic Allicin ox-LDL induced HUVECs Caspase3↓ 10–100 μM 24 h N Chen et al. (2016)
NADPH↓
Allicin LPS induced HUVECs MMPs collapse↓ 0–40 μg/ml 24 h N Zhang et al. (2017)
Cytochrome c↓
Allicin H2O2 induced HUVECs Pro-Caspase-3 Protein↓ 1, 10, 20, 40 μg/ml 6, 12, 24 h N Chen et al. (2014)
PARP↓
Bax↓
SOD↑
NO↑
eNOS↑
MDA↓
Garlic oil High cholesterol diet-induced Golden Syrian hamsters (145—170 g) PI3K-Akt↑ 2% cholesterol and 1% garlic oil (po., n = 8) 8 w N Cheng et al. (2013)
TNF-α↓
Fas↓
caspase 8, 9, 3↓
Bcl-2↑
Bid↓
Bax↓
Inhibit smooth muscle proliferation MATs Insulin or PDGF induced VSMCs PGGTase-I↓ 50 mol/L 24 h N Golovchenko et al. (2003)
AGE. Cholesterol supplemented standard diet-induced New Zealand rabbits with carotid intima thickening (3–4 m) PDGF↓ 800 μl/kg·bw/d (po., n = 6) 6 w N Efendy et al. (1997)
Regulating gut microbiota Alliin High-fat diet-induced C57BL/6J mices (8 w) Lachnospiraceae↓ 0.1 mg/ml (po., n = 20) 8 w N Zhai et al. (2018)
Ruminococcaceae↑
Allicin High-TMAO patients Prausnitzii↑ 0.89 mg/ml (po., n = 7) 1 w N Panyod et al. (2022)
Akkermansia spp↑

FIGURE 5.

FIGURE 5

Mechanisms of the protective role of garlic in the treatment of atherosclerosis. ACAT, cholesterol acyltransferase; CEH, Cholesteryl ester hydrolase; LCAT, Lecithin cholesterol acyltransferase; LPL, Lipoprotein lipase; HL, Hepatic lipase; MTP, Microsomal triglyceride transfer protein; ABCA1, ATP Binding Cassette Subfamily A Member 1; HMGCR, Hydroxy-3-methyl glutaryl coenzyme A reductase; AMPK, AMP-activated protein kinase; FAS, Fatty acid synthase; SREBP, Sterol regulatory element-binding protein; TLR, Toll-like receptors; CRP, C-reaction protein; PPARγ, Peroxisome proliferator-activated receptor Gamma; LXRα, Liver X receptor α; IL-10, Interleukin-10; SHIP1, Src homology-2-containing inositol 5′-phosphatase 1; STAT3, Signal transducer and activator of transcription 3; Arg1, Arginase1; IRAK4, Interleukin-1 receptor-activated kinase 4; NF-κB, Nuclear factor kappa-B; IFN-g, Interferon gamma; NADPH, Nicotinamide adenine dinucleotide phosphate; PARP, Poly adenosine diphosphate-ribose polymerase; MMPs, Matrix metalloproteinases; TNF-α, Tumor necrosis factor-α; Fas, Fatty acid synthase; Bax, BCL2-Associated X; Bid, Recombinant Human BH3-Interacting Domain Death Agonist; Bcl-2, B-cell lymphoma-2; CaSR, Calcium-sensing receptor; eNOS, Endothelin nitric oxide synthase; ICAM-1, Intercellular cell adhesion molecule-1; VCAM-1, Vascular Cell Adhesion Molecule 1; ERK1/2, Extracellular regulated protein kinases; bFGF, Basic fibroblast growth factor; VEGF, Vascular endothelial growth factor; SIRT1, Sirtuin 1; ROS, Reactive oxygen species; PAI-1, Plasminogen Activator Inhibitor-1; GSH, Glutathione; SOD, Superoxide Dismutase; NQO1, NAD(P)H:quinone oxidoreductase 1; γ-GCSc, γ -glutamylcysteine synthetase antibody; SOD-1, Superoxide Dismutase 1; MDA, Malondialdehyde; TXB2, Thromboxane B2.

The risk of AS progression is significantly increased in postmenopausal women, semmingly retale to decline level of estrogen secretion. The use of the dietary supplement “Karinat”, which is isoflavonoid-rich preparation containing tannins from garlic powder and other herbs, was proved to decrease total cholesterol by 6.3% and lower carotid intima-media thickness progression in postmenopausal women (Myasoedova et al., 2016).

Pharmacokinetic studies of garlic

Few pharmacokinetic studies of garlic have been conducted, mainly focusing on alliin, SAC, and DATS. Three groups of rats received 8 mg/kg of alliin and allicin. The absorption and elimination of alliin radioactivity were significantly faster than other garlic components, reaching maximum blood levels within the first 10 min and almost eliminated from the blood after 6 h. Allicin did not reach maximum blood levels until 30–60 min and still existed at the end of the study after 72 h with blood levels >1000 ng-Eq/ml. The mean total urinary and fecal excretion of Allicin after 72 h was 85.5% of the dose, with urinary excretion indicating a minimum absorption rate of 65% (Perez et al., 2014). After injecting 10 mg DATS into the jugular vein of rats, the plasma concentration of DATS reached the peak of 31 μm within 1 min and gradually returned to the baseline level within 24 h. DATS was injected intravenously into rats with microemulsion, and the plasma concentration of DATS reached its peak within 3 h. Following the ingestion of DATS by human subjects, the breakdown product Allyl methyl sulfide (AMS) concentration increased to a peak at 5 h. Furthermore, following ingestion of raw garlic, AMS, allyl methyl disulfide (AMDS), DAS, DADS, DATS, and dimethyl sulfide were detected in the volunteers’ breath. The concentrations of AMDS, DAS, DADS, and DATS peaked within 2–3 h, while the concentrations of the other compounds increased more slowly (Morihara et al., 2017). Further pharmacokinetic studies of garlic are needed to determine its potential to treat AS.

Adverse reactions and toxicity

Although garlic is generally considered safe for humans, it can still cause adverse reactions in sensitive individuals when ingested at high doses. A randomized controlled trial was conducted in which ingestion of high doses of raw garlic on an empty stomach caused changes in the intestinal flora, flatulence, and gastrointestinal disturbances to assess the safety of garlic (Rana et al., 2011). In addition, blisters, dermatitis, and burns can be observed by topical application of raw garlic (Piasek et al., 2009). In vivo experiments have shown that prolonged intake of high doses of raw garlic can lead to weight loss and hemolytic anemia. In addition, chronic administration of 50 mg of garlic powder per day produces anti-androgenic effects, leading to reduced sialic acid concentrations in the seminal vesicles, testes, and epididymis and reduced interstitial cell function (Rana et al., 2011). The primary toxicological mechanism of sulfide in garlic is oxidative hemolysis, which is characterized by methemoglobinemia and the formation of Heinz bodies. Early clinical signs include depression, vomiting, loss of appetite, abdominal pain, diarrhea, pale mucous membranes of the fundus, jaundice, increased heart and respiratory rates, weakness, and hemoglobinuria (Salgado et al., 2011). A low dose of garlic is safe, therapeutic dose may cause mild gastrointestinal disorder, while a high dose of garlic may cause liver damage (Rahman et al., 2016). The antithrombotic activity of garlic may interact with oral anticoagulants, so care must be taken when used in concert with oral anticoagulants (Rose et al., 1990). Allicin is a membrane-permeable compound that readily enters cells and interacts with sulfhydryl-containing compounds in cells, such as GSH or cysteine residues in proteins and enzymes containing active cysteine, resulting in cytotoxicity of allicin.

Quality control of garlic

The quality standards of garlic or related species are included in the United States Pharmacopoeia, the European Pharmacopoeia, and the British Pharmacopoeia. The quality standards of garlic were included in the 1977 edition of the Chinese Pharmacopoeia. However, the quality standard for garlic was not found in subsequent editions of the Pharmacopoeia until it was reintroduced in the 2010 edition of the Chinese Pharmacopoeia. Since thiosulfinate and decomposition products are biologically active, and the primary precursor substance is alliin, the leading testing indexes for garlic and garlic-related species internationally are the content of alliin, the activity of allinase or the content of potential allicin. Other indicators are tested for garlic preparations prepared for various purposes and methods. The British, American, and European Pharmacopoeias all contain garlic or related preparations, with alliin or potential allicin as the leading indicator for product quality control. The United States Pharmacopoeia contains the most varieties of garlic, while the British and European Pharmacopoeia only contains garlic powder. Garlic oil is extracted from crushed garlic and includes only the fat-soluble sulfide DAS, DADS, DATS, etc., after the decomposition of allicin, but no water-soluble components and alliin. Garlic extract is extracted by organic solvent, which inhibits allinase activity, and the extract consists of fat-soluble sulfide and allicin without allicin. The preparation prepared by pulverizing garlic cloves into powder contains alliin and a small amount of fat-soluble sulfide (Harauma and Moriguchi, 2006; Corzo-Martínez et al., 2007). Freeze-dried garlic powder and its preparations made from garlic by low-temperature freeze-drying can produce allicin under suitable conditions in vivo due to the retention of alliin and active allinase. Therefore the European Pharmacopoeia and the United States Pharmacopoeia require determining the potential allicin content for the corresponding preparations and raw materials.

Conclusion and perspective

The antiatherogenic effects and mechanisms of garlic were discussed in this review, and it was thought that further research should be conducted in the future on the following aspects. Garlic contains multi-bioactive components, such as allicin, DAS, DADS, and DATS, among which allicin is the primary bioactive substance of garlic. DATS has been included in the Chinese Pharmacopoeia (Chinese Pharmacopoeia Commission, 2015), and alliin and allicin have been included in the European Pharmacopoeia (European Pharmacopoeia, 2017). The research progress of Allicin is restricted because of its unstable chemical properties and difficulties in preparation and storage. China has established a patented technology for preparing Allicin, which can extract more stable and higher purity allicin, making it possible to conduct in-depth research. Therefore, there is an urgent need to conduct pharmacological studies on garlic and its active ingredients in the future to clarify the actual active ingredients of garlic as soon as possible.

Recent studies have shown that whole garlic or its components/extracts exhibit multiple preventive and therapeutic effects on AS. The formation of AS is a multifactorial interaction, so it should be studied in depth from various pathways, links, and targets. The biological effects of garlic may meet the need for a multi-targeted therapeutic strategy for AS. However, some contradictory results may be related to the inconsistency between the quality, extraction, preparation, and dosage of garlic and the experimental objects and methods. Therefore, future research on garlic should be deepened in the above aspects. Garlic may exert antiatherogenic effects through hypolipidemic, antioxidant, antithrombotic, inhibiting angiogenesis, protecting endothelial cells, anti-inflammatory, anti-apoptotic, inhibiting vascular smooth muscle proliferation, and regulating gut microbiota. However, the potential mechanisms of absorption, distribution, metabolism, and excretion of garlic and its components/extracts and the synergistic or antagonistic effects between components are unknown, for which further studies should be conducted.

Garlic can treat AS by regulating different signaling pathways, such as AMPK/TLRs, Keap1/Nrf2, PI3K/AKT, PPARγ/LXRα, GEF-H1/RhoA/Rac, etc. However, there is still no molecular mechanism for clinical AS patients. Therefore, the direct AS protection mechanisms of garlic have not been explored. Further studies in animals and humans should evaluate the protective ability of single garlic-derived compounds against AS. Future studies should also focus on the beneficial effects of whole garlic and garlic-derived compounds on AS based on relevant signaling pathways. There have been few clinical trials to monitor garlic’s therapeutic effect in recent years. Therefore, there is an urgent need for large randomized, controlled, and double-blind trials to assess the efficacy and safety of garlic in the treatment of AS from the perspective of clinical practice. In addition, it will make the clinical application of garlic safer and more effective in solving the adverse reactions of garlic by inhibiting oxidized hemolysate and reducing the risk of bleeding.

Author contributions

ML and WY contributed equally to this manuscript. QH designed the study and was the corresponding author. GW and QH drafted the figure. JG and AL drafted the table. ML and WY drafted the initial full manuscript. All authors approved the final version of the manuscript.

Funding

This work was funded by the Beijing-Tianjin-Hebei Basic Research Cooperation Project (No. J200020).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2022.954938/full#supplementary-material

Glossary

5-HT

5-hydroxy tryptamine

6-keto-PGF1α

6-keto-prostaglandin F1α

AA

Arachidonic acid

ABCA1

ATP Binding Cassette Subfamily A Member 1

ACAT

Acyl-CoA:cholesterol acyltransferase

ACE

Angiotensin-Converting Enzyme

AGE

Aged garlic extract

AMPK

AMP-activated protein kinase

APTT

Activated partial thromboplasting time

Arg1

Arginase1

AS

Atherosclerosis

Bax

BCL2-Associated X

Bcl-2

B-cell lymphoma-2

bFGF

Basic fibroblast growth factor

Bid

Recombinant Human BH3-Interacting Domain Death Agonist

CAM

Complementary and alternate medicine

CaMKK

Calcium/calmodulin-dependent kinase kinase

CaSR

Calcium-sensing receptor

CD36

Cluster of differentiation 36

CEH

Cholesteryl ester hydrolase

cGMP

Cyclic guanosine monophosphate

CHD

Coronary artery heart disease

COX1

Cyclooxygenase-1

COX2

Cyclooxygenase-2

CRP

C-reaction protein

CVDs

Cardiovascular diseases

DADS

Diallyl disulfide

DAS

Diallyl sulfide

DATS

Diallyl trisulfide

DATTS

Diallyl Tetrasulfide

DIO

Diet-induced obese

ECs

Endothelial cells

EDHF

Endothelium-derived hyperpolarizing factor

ELAM-1

Endothelial leukocyte adhesion molecule-1

eNOS

Endothelin nitric oxide synthase

ERK1/2

Extracellular regulated protein kinases

ET1

Endothelin-1

FAS

Fatty acid synthase

FGE

Fresh garlic extract

FMD

Flow-mediated dilation

G6PDH

Glucose-6-Phosphate Dehydrogenase

GEF-H1

Guanine nucleotide exchange factor-H1

GMP140

Granular membrane protein 140

GPE

Garlic powder extract

GSH

Glutathione

GSH-Px

Glutathione peroxidase

HDL

High-density lipoprotein

HIF2α

Hypoxia-inducible factor 2α

HL

Hepatic lipase

HMGCR

Hydroxy-3-methyl glutaryl coenzyme A reductase

hsCRP

High-sensitivity C-reactive protein

HUVECs

Human umbilical vein endothelial cells

ICAM-1

Intercellular cell adhesion molecule-1

IFN-g

Interferon gamma

IL-10

Interleukin-10

IL-10Rα

IL-10 receptor α

IL-12β

Interleukin-12 beta

IL-18

Interleukin 18

IL-1a

Interleukin-1 alpha

IL-1β

Interleukin-1 beta

IL-6

Interleukin- 6

IL-8

Interleukin-8

iNOS

Inducible nitric oxide synthase

IRAK4

Interleukin-1 receptor-activated kinase 4

JAK3

Janus Kinase 3

JNK

C-Jun N-terminal kinase

LCAT

Lecithin cholesterol acyltransferase

LDL

Low-density lipoprotein

LDL-C

Low-density lipoprotein cholesterol

L-NAME

L-N G-Nitro arginine methyl ester

LPL

Lipoprotein lipase

LPS

Lipopolysaccharide

LTC4C

Leukotriene C4

LXRα

Liver X receptor α

MAPK

Mitogen-activated protein kinase

MATS

Methyl allyl trisulfide

MCP-1

Monocyte chemotactic protein 1

MDA

Malondialdehyde

MLC

Myosin light chain

MMPs

Matrix metalloproteinases

MTTP

Microsomal triglyceride transfer protein

Macrophages

NAC

N-acetylcysteine

NADPH

Nicotinamide adenine dinucleotide phosphate

NF-κB

Nuclear factor kappa-B

NO

Nitric oxide

NOS

Nitric oxide synthase

NQO1

NAD(P)H:quinone oxidoreductase 1

Nrf2

Nuclear erythroid 2-related factor 2

OS

Oxidative stress

ox-LDL

LDL oxidation

p38 MAPK

P38 mitogen-activated protein kinase

PAI-1

Plasminogen Activator Inhibitor-1

PARP

Poly adenosine diphosphate-ribose polymerase

PDGF

Platelet-Derived Growth Factor

PGE2

Prostaglandin E2

PGGTase-I

Protein geranylgeranyltransferase type I

PGI2

Prostaglandin I2

PPARα

Peroxisome proliferator-activated receptor alpha

PPARγ

Peroxisome proliferator-activated receptor Gamma

RhoA

Ras homolog gene family, member A

RNS

Reactive nitrogen species

ROS

Reactive oxygen species

S1PC

S-1-propenylcysteine

SAC

S-allyl cysteine

SACS

S-allyl cysteine sulfoxide

SEC

S-acetylcysteine

SHIP1

Src homology-2-containing inositol 5′-phosphatase 1

SI

Stiffness index

SIRT1

Sirtuin 1

STAT3

Signal transducer and activator of transcription 3

SOD

Superoxide Dismutase

SOD-1

Superoxide Dismutase 1

SPC

S-propylcysteine

SR-A

Scavenger receptor class A

SREBP-1

Sterol regulatory element-binding proteins-1

SREBP-1c

Sterol regulatory element-binding protein-1c

SREBP-2

Sterol regulatory element-binding protein-2

T-AOC

Total antioxidant capacit

TAS

Total antioxidant status

TC

Total cholesterol

TF

Tissue factor

Th1

Thelper 1 cell

TLR

Toll-like receptors

TNF-α

Tumor necrosis factor-α

TSG

Total Saponins of Garlic

TSOD

Tsumura Suzuki Obese Diabetes

TXA2

Thromboxane A2

TXB2

Thromboxane B2

VCAM-1

Vascular Cell Adhesion Molecule 1

VEGF

Vascular endothelial growth factor

VEGF R2

Vascular endothelial growth factor receptor 2

VSMCs

Vascular smooth muscle cells

γ-GCSc

γ -glutamylcysteine synthetase antibody

References

  1. Almatroodi S. A., Alsahli M. A., Almatroudi A., Rahmani A. H. (2019). Garlic and its active compounds: A potential candidate in the prevention of cancer by modulating various cell signalling pathways. Anticancer Agents Med. Chem. 19, 1314–1324. 10.2174/1871520619666190409100955 [DOI] [PubMed] [Google Scholar]
  2. Arellano-Buendía A. S., Castañeda-Lara L. G., Loredo-Mendoza M. L., García-Arroyo F. E., Rojas-Morales P., Argüello-García R., et al. fnm (2020). Effects of allicin on pathophysiological mechanisms during the progression of nephropathy associated to diabetes. Antioxidants (Basel, Switz. 9, 1134. 10.3390/antiox9111134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Argüello-García R., Medina-Campos O. N., Pérez-Hernández N., Pedraza-Chaverrí J., Ortega-Pierres G. (2010). Hypochlorous acid scavenging activities of thioallyl compounds from garlic. J. Agric. Food Chem. 58, 11226–11233. 10.1021/jf102423w [DOI] [PubMed] [Google Scholar]
  4. Ariga T., Oshiba S., Tamada T. (1981). Platelet aggregation inhibitor in garlic. Lancet 1, 150–151. 10.1016/s0140-6736(81)90729-7 [DOI] [PubMed] [Google Scholar]
  5. Barnes P. M., Bloom B., Nahin R. L. (2008). Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Rep. 10, 1–23. 10.1037/e623942009-001 [DOI] [PubMed] [Google Scholar]
  6. Bat-Chen W., Golan T., Peri I., Ludmer Z., Schwartz B. (2010). Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutr. Cancer 62, 947–957. 10.1080/01635581.2010.509837 [DOI] [PubMed] [Google Scholar]
  7. Block E., Ahmad S., Catalfamo J. L., Jain M. K., Apitz-Castro R. (1986). The chemistry of alkyl thiosulfinate esters. 9. Antithrombotic organosulfur compounds from garlic: Structural, mechanistic, and synthetic studies. J. Am. Chem. Soc. 108, 7045–7055. 10.1021/ja00282a033 [DOI] [Google Scholar]
  8. Block E. (1985). The chemistry of garlic and onions. Sci. Am. 252, 114–119. 10.1038/scientificamerican0385-114 [DOI] [PubMed] [Google Scholar]
  9. Block E. (1985). The chemistry of garlic and onions. Sci. Am. 252 (3), 114–119. 10.1038/scientificamerican0385-114 [DOI] [PubMed] [Google Scholar]
  10. Bordia A., Verma S. K., Srivastava K. C. (1998). Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostagl. Leukot. Essent. Fat. Acids. 58, 257–263. 10.1016/s0952-3278(98)90034-5 [DOI] [PubMed] [Google Scholar]
  11. Bordia T., Mohammed N., Thomson M., Ali M. (1996). An evaluation of garlic and onion as antithrombotic agents. Prostagl. Leukot. Essent. Fat. Acids. 54, 183–186. 10.1016/s0952-3278(96)90014-9 [DOI] [PubMed] [Google Scholar]
  12. Bouillaud F., Blachier F. (2011). Mitochondria and sulfide: A very old story of poisoning, feeding, and signaling. Antioxid. Redox Signal. 15, 379–391. 10.1089/ars.2010.3678 [DOI] [PubMed] [Google Scholar]
  13. Brandolini V., Tedeschi P., Cereti E., Maietti A., Barile D., Coïsson J. D., et al. (2005). Chemical and genomic combined approach applied to the characterization and identification of Italian Allium sativum L. J. Agric. Food Chem. 53, 678–683. 10.1021/jf0489623 [DOI] [PubMed] [Google Scholar]
  14. Brown D. G., Wilkerson E. C., Love W. E. (2015). A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. J. Am. Acad. Dermatol. 72, 524–534. 10.1016/j.jaad.2014.10.027 [DOI] [PubMed] [Google Scholar]
  15. Canugovi C., Stevenson M. D., Vendrov A. E., Hayami T., Robidoux J., Xiao H., et al. (2019). Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening. Redox Biol. 26, 101288. 10.1016/j.redox.2019.101288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cao H., Chen J. (2008). Study of extraction and purification of alliinase from garlic and its clinical application. Proceeding Clin. Med. 17, 83–86. 10.3969/j.issn.1671-8631.2008.02.001 [DOI] [Google Scholar]
  17. Cavallito C. J., Bailey J. H. (1944). Allicin, the antibacterial principle of allium sativum. I. Isolation, physical properties and antibacterial action. J. Am. Chem. Soc. 66, 1950–1951. 10.1021/ja01239a048 [DOI] [Google Scholar]
  18. Chen S., Tang Y., Qian Y., Chen R., Zhang L., Wo L., et al. (2014). Allicin prevents H₂O₂-induced apoptosis of HUVECs by inhibiting an oxidative stress pathway. BMC Complement. Altern. Med. 14, 321. 10.1186/1472-6882-14-321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chen X., Pang S., Lin J., Xia J., Wang Y. (2016). Allicin prevents oxidized low-density lipoprotein-induced endothelial cell injury by inhibiting apoptosis and oxidative stress pathway. BMC Complement. Altern. Med. 16, 133. 10.1186/s12906-016-1126-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cheng Y. C., Chang M. H., Tsai C. C., Chen T. S., Fan C. C., Lin C. C., et al. (2013). Garlic oil attenuates the cardiac apoptosis in hamster-fed with hypercholesterol diet. Food Chem. 136, 1296–1302. 10.1016/j.foodchem.2012.09.076 [DOI] [PubMed] [Google Scholar]
  21. China Cardiovascular Health and Disease Report Writing Group (2021). China cardiovascular health and disease report 2020. Chin. Circulation J. 6, 885–889. 10.3969/j.issn.1007-5062.2021.09.001 [DOI] [Google Scholar]
  22. Chinese Pharmacopoeia Commission (2015). Pharmacopoeia of the people's Republic of China. Beijing: China Medical Science Press. Part I. [Google Scholar]
  23. Chistiakov D. A., Orekhov A. N., Bobryshev Y. V. (2015). Endothelial barrier and its abnormalities in cardiovascular disease. Front. Physiol. 6, 365. 10.3389/fphys.2015.00365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Corzo-Martínez M., Corzo N., Villamiel M. (2007). Biological properties of onions and garlic. Trends Food Sci. Technol. 18, 609–625. 10.1016/j.tifs.2007.07.011 [DOI] [Google Scholar]
  25. Dahlbäck B. (2000). Blood coagulation. Lancet 355, 1627–1632. 10.1016/S0140-6736(00)02225-X [DOI] [PubMed] [Google Scholar]
  26. de Nigris F., Rienzo M., Sessa M., Infante T., Cesario E., Ignarro L. J., et al. (2012). Glycoxydation promotes vascular damage via MAPK-ERK/JNK pathways. J. Cell. Physiol. 227, 3639–3647. 10.1002/jcp.24070 [DOI] [PubMed] [Google Scholar]
  27. Donato A. J., Machin D. R., Lesniewski L. A. (2018). Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ. Res. 123, 825–848. 10.1161/CIRCRESAHA.118.312563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Efendy J. L., Simmons D. L., Campbell G. R., Campbell J. H. (1997). The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis. Atherosclerosis 132, 37–42. 10.1016/s0021-9150(97)00078-6 [DOI] [PubMed] [Google Scholar]
  29. El-Sheakh A. R., Ghoneim H. A., Suddek G. M., Ammar E. (2016). Attenuation of oxidative stress, inflammation, and endothelial dysfunction in hypercholesterolemic rabbits by allicin. Can. J. Physiol. Pharmacol. 94, 216–224. 10.1139/cjpp-2015-0267 [DOI] [PubMed] [Google Scholar]
  30. Elkayam A., Peleg E., Grossman E., Shabtay Z., Sharabi Y. (2013). Effects of allicin on cardiovascular risk factors in spontaneously hypertensive rats. Israel Med. Assoc. J. IMAJ. 15, 170–173. 10.5152/balkanmedj.2012.115 [DOI] [PubMed] [Google Scholar]
  31. Elosta A., Slevin M., Rahman K., Ahmed N. (2017). Aged garlic has more potent antiglycation and antioxidant properties compared to fresh garlic extract in vitro . Sci. Rep. 7, 39613. 10.1038/srep39613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. European Pharmacopoeia (2017). Europäisches arzneibuch vol. 9.0. (Stuttgart, Germany: Deutscher Apotheker Verlag; ), 2359–2360. [Google Scholar]
  33. Ferri N., Yokoyama K., Sadilek M., Paoletti R., Apitz-Castro R., Gelb M. H., et al. (2003). Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation. Br. J. Pharmacol. 138, 811–818. 10.1038/sj.bjp.0705126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Frass M., Strassl R. P., Friehs H., Müllner M., Kundi M., Kaye A. D. (2012). Use and acceptance of complementary and alternative medicine among the general population and medical personnel: A systematic review. Ochsner J. 12, 45–56. [PMC free article] [PubMed] [Google Scholar]
  35. Gardner C. D., Lawson L. D., Block E., Chatterjee L. M., Kiazand A., Balise R. R., et al. (2007). Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: A randomized clinical trial. Arch. Intern. Med. 167, 346–353. 10.1001/archinte.167.4.346 [DOI] [PubMed] [Google Scholar]
  36. Gimbrone M. A., Jr, García-Cardeña G. (2016). Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res. 118, 620–636. 10.1161/CIRCRESAHA.115.306301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Golovchenko I., Yang C. H., Goalstone M. L., Draznin B. (2003). Garlic extract methylallyl thiosulfinate blocks insulin potentiation of platelet-derived growth factor-stimulated migration of vascular smooth muscle cells. Metab. Clin. Exp. 52, 254–259. 10.1053/meta.2003.50042 [DOI] [PubMed] [Google Scholar]
  38. Grover S. P., Mackman N. (2020). Tissue factor in atherosclerosis and atherothrombosis. Atherosclerosis 307, 80–86. 10.1016/j.atherosclerosis.2020.06.003 [DOI] [PubMed] [Google Scholar]
  39. HALE Collaborators (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the global burden of disease study 2016. Lancet 390, 1260–1344. 10.1016/S0140-6736(17)32130-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Harauma A., Moriguchi T. (2006). Aged garlic extract improves blood pressure in spontaneously hypertensive rats more safely than raw garlic. J. Nutr. 136, 769S–773S. 10.1093/jn/136.3.769S [DOI] [PubMed] [Google Scholar]
  41. Hitchcock J. K., Mkwanazi N., Barnett C., Graham L. M., Katz A. A., Hunter R., et al. (2021). The garlic compound Z-ajoene, S-thiolates COX2 and STAT3 and dampens the inflammatory response in RAW264.7 macrophages. Mol. Nutr. Food Res. 65, e2000854. 10.1002/mnfr.202000854 [DOI] [PubMed] [Google Scholar]
  42. Ho S. E., Ide N., Lau B. H. (2001). S-allyl cysteine reduces oxidant load in cells involved in the atherogenic process. Phytomedicine 8, 39–46. 10.1078/0944-7113-00005 [DOI] [PubMed] [Google Scholar]
  43. Hofmann S., Grasberger H., Jung P., Bidlingmaier M., Vlotides J., Janssen O. E., et al. (2002). The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression. Eur. J. Med. Res. 7, 171–176. [PubMed] [Google Scholar]
  44. Hong J. Y., Wang Z. Y., Smith T. J., Zhou S., Shi S., Pan J., et al. (1992). Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis 13, 901–904. 10.1093/carcin/13.5.901 [DOI] [PubMed] [Google Scholar]
  45. Hu B., Kuang H., Xin Y., Wang Y., Wang Z., Jiang H., et al. (2019). Lipid-lowering activity and mechanism of allii sativi bulbus. Chin. J. Exp. Traditional Med. Formulae 25, 181–186. 10.13422/j.cnki.syfjx.20190808 [DOI] [Google Scholar]
  46. Hu H., Pan Y., Fan X., Hu X., Zou W., Lin X. (2016). Allicin inhibits H_20_2-induced senescence in human umbilical vein endothelial cells through activation of sirt1. Chin. J. Biochem. Mol. Biol. 32, 536–543. 10.13865/j.cnki.cjbmb.2016.05.09 [DOI] [Google Scholar]
  47. Hwang Y. P., Kim H. G., Choi J. H., Do M. T., Chung Y. C., Jeong T. C., et al. (2013). S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. J. Nutr. Biochem. 24, 1469–1478. 10.1016/j.jnutbio.2012.12.006 [DOI] [PubMed] [Google Scholar]
  48. Ide N., Lau B. H. (2001). Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-kappa b activation. J. Nutr. 131, 1020S–6S. 10.1093/jn/131.3.1020S [DOI] [PubMed] [Google Scholar]
  49. Ilić D. P., Stojanović S., Najman S., Nikolić V. D., Stanojević L. P., Tačić A., et al. (2015). Biological evaluation of synthesized allicin and its transformation products obtained by microwaves in methanol: Antioxidant activity and effect on cell growth. Biotechnol. Biotechnol. Equip. 29, 189–194. 10.1080/13102818.2014.994267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Irfan M., Kim M., Kim K. S., Kim T. H., Kim S. D., Hong S. B., et al. (2019). Fermented garlic ameliorates hypercholesterolemia and inhibits platelet activation. Evid. Based Complement. Altern. Med. 2019, 3030967. 10.1155/2019/3030967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Jamil H., Gordon D. A., Eustice D. C., Brooks C. M., Dickson J. K., Jr, Chen Y., et al. (1996). An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. Proc. Natl. Acad. Sci. U. S. A. 93, 11991–11995. 10.1073/pnas.93.21.11991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Javadifar A., Rastgoo S., Banach M., Jamialahmadi T., Johnston T. P., Sahebkar A. (2021). Foam cells as therapeutic targets in atherosclerosis with a focus on the regulatory roles of non-coding RNAs. Int. J. Mol. Sci. 22, 2529. 10.3390/ijms22052529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kamenetsky R., Shafir I. L., Khassanov F., Kik C., Heusden A., Ginkel V. V., et al. (2005). Diversity in fertility potential and organo-sulphur compounds among garlics from Central Asia. Biodivers. Conservation 14, 281–295. 10.1007/s10531-004-5050-9 [DOI] [Google Scholar]
  54. Kattoor A. J., Kanuri S. H., Mehta J. L. (2019). Role of ox-LDL and LOX-1 in atherogenesis. Curr. Med. Chem. 26, 1693–1700. 10.2174/0929867325666180508100950 [DOI] [PubMed] [Google Scholar]
  55. Kendler B. S. (1987). Garlic (allium sativum) and onion (Allium cepa): A review of their relationship to cardiovascular disease. Prev. Med. 16, 670–685. 10.1016/0091-7435(87)90050-8 [DOI] [PubMed] [Google Scholar]
  56. Kim K. M., Chun S. B., Koo M. S., Choi W. J., Kim T. W., Kwon Y. G., et al. (2001). Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic. Biol. Med. 30, 747–756. 10.1016/s0891-5849(01)00460-9 [DOI] [PubMed] [Google Scholar]
  57. Kim L., Lim Y., Park S. Y., Kim Y. J., Kwon O., Lee J. H., et al. (2018). A comparative study of the antithrombotic effect through activated endothelium of garlic powder and tomato extracts using a rodent model of collagen and epinephrine induced thrombosis. Food Sci. Biotechnol. 27, 1513–1518. 10.1007/s10068-018-0469-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Kobiyama K., Ley K. (2018). Atherosclerosis: A chronic inflammatory disease with an autoimmune. Compon. Circ. Res. 123, 1118–1120. 10.1161/CIRCRESAHA.118.313816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Kockx M. M., Cromheeke K. M., Knaapen M. W., Bosmans J. M., De Meyer G. R., Herman A. G., et al. (2003). Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 440–446. 10.1161/01.ATV.0000057807.28754.7F [DOI] [PubMed] [Google Scholar]
  60. Kunimura K., Miki S., Takashima M., Suzuki J. I. (2021). S-1-propenylcysteine improves TNF-α-induced vascular endothelial barrier dysfunction by suppressing the GEF-H1/RhoA/Rac pathway. Cell Commun. Signal 19, 17. 10.1186/s12964-020-00692-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Kwak J. S., Kim J. Y., Paek J. E., Lee Y. J., Kim H. R., Park D. S., et al. (2014). Garlic powder intake and cardiovascular risk factors: A meta-analysis of randomized controlled clinical trials. Nutr. Res. Pract. 8, 644–654. 10.4162/nrp.2014.8.6.644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Lanzotti V. (2006). The analysis of onion and garlic. J. Chromatogr. A 1112, 3–22. 10.1016/j.chroma.2005.12.016 [DOI] [PubMed] [Google Scholar]
  63. Lawson L. D., Gardner C. D. (2005). Composition, stability, and bioavailability of garlic products used in a clinical trial. J. Agric. Food Chem. 53, 6254–6261. 10.1021/jf050536+ [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Lawson L. D., Wang Z. J., Hughes B. G. (1991). Identification and HPLC quantitation of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Med. 57, 363–370. 10.1055/s-2006-960119 [DOI] [PubMed] [Google Scholar]
  65. Lee H. H., Han M. H., Hwang H. J., Kim G. Y., Moon S. K., Hyun J. W., et al. (2015). Diallyl trisulfide exerts anti-inflammatory effects in lipopolysaccharide-stimulated RAW 264.7 macrophages by suppressing the Toll-like receptor 4/nuclear factor-κB pathway. Int. J. Mol. Med. 35, 487–495. 10.3892/ijmm.2014.2036 [DOI] [PubMed] [Google Scholar]
  66. Lestari S. R., Atho'illah M. F., Christina Y. I., Rifa'i M. (2020). Single garlic oil modulates T cells activation and proinflammatory cytokine in mice with high fat diet. J. Ayurveda Integr. Med. 11, 414–420. 10.1016/j.jaim.2020.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Li C., Cai F., Wu J., Chen J. (2003). Effect of Garlic polysaccharide on lipid peroxidation and nitric oxide in mice with viral myocarditis. Mod. J. Integr. Traditional Chin. West. Med. 12, 2636–2638. 10.3969/j.issn.1008-8849.2003.24.006 [DOI] [Google Scholar]
  68. Li F., Li Q., Wu S., Tan Z. (2017). Salting-out extraction of allicin from garlic (Allium sativum L.) based on ethanol/ammonium sulfate in laboratory and pilot scale. Food Chem. 217, 91–97. 10.1016/j.foodchem.2016.08.092 [DOI] [PubMed] [Google Scholar]
  69. Li F., Zhang J., He P., Li Y. (2016). Prospects for garlic sulfur compounds developing into hydrogen sulfide donor drugs. Traditional Chin. Drug Res. Clin. Pharmacol. 27, 588–592. 10.19378/j.issn.1003-9783.2016.04.025 [DOI] [Google Scholar]
  70. Li Z., Yang F., Dunn S., Gross A. K., Smyth S. S. (2011). Platelets as immune mediators: Their role in host defense responses and sepsis. Thromb. Res. 127, 184–188. 10.1016/j.thromres.2010.10.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Lin C. C., Yin M. C. (2008). Effects of cysteine-containing compounds on biosynthesis of triacylglycerol and cholesterol and anti-oxidative protection in liver from mice consuming a high-fat diet. Br. J. Nutr. 99, 37–43. 10.1017/S0007114507793881 [DOI] [PubMed] [Google Scholar]
  72. Lin M. C., Wang E. J., Lee C., Chin K. T., Liu D., Chiu J. F., et al. (2002). Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine. J. Nutr. 132, 1165–1168. 10.1093/jn/132.6.1165 [DOI] [PubMed] [Google Scholar]
  73. Lin X. L., Hu H. J., Liu Y. B., Hu X. M., Fan X. J., Zou W. W., et al. (2017). Allicin induces the upregulation of ABCA1 expression via PPARγ/LXRα signaling in THP-1 macrophage-derived foam cells. Int. J. Mol. Med. 39, 1452–1460. 10.3892/ijmm.2017.2949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Liperoti R., Vetrano D. L., Bernabei R., Onder G. (2017). Herbal medications in cardiovascular medicine. J. Am. Coll. Cardiol. 69, 1188–1199. 10.1016/j.jacc.2016.11.078 [DOI] [PubMed] [Google Scholar]
  75. Liu L. L., Yan L., Chen Y. H., Zeng G. H., Zhou Y., Chen H. P., et al. (2014). A role for diallyl trisulfide in mitochondrial antioxidative stress contributes to its protective effects against vascular endothelial impairment. Eur. J. Pharmacol. 725, 23–31. 10.1016/j.ejphar.2014.01.010 [DOI] [PubMed] [Google Scholar]
  76. Liu L., Yeh Y. Y. (2002). S-alk(en)yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase in cultured rat hepatocytes. J. Nutr. 132, 1129–1134. 10.1093/jn/132.6.1129 [DOI] [PubMed] [Google Scholar]
  77. Liu Q., Li J., Hartstone-Rose A., Wang J., Li J., Janicki J. S., et al. (2015). Chinese herbal compounds for the prevention and treatment of atherosclerosis: Experimental evidence and mechanisms. Evid. Based Complement. Altern. Med. 2015, 752610. 10.1155/2015/752610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Makheja A. N., Bailey J. M. (1990). Antiplatelet constituents of garlic and onion. Agents actions 29, 360–363. 10.1007/BF01966468 [DOI] [PubMed] [Google Scholar]
  79. Matsumoto S., Nakanishi R., Li D., Alani A., Rezaeian P., Prabhu S., et al. (2016). Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with metabolic syndrome in a prospective randomized double-blind study. J. Nutr. 146, 427S–432S. 10.3945/jn.114.202424 [DOI] [PubMed] [Google Scholar]
  80. Matsuura H. (2001). Saponins in garlic as modifiers of the risk of cardiovascular disease. J. Nutr. 131, 1000S–5S. 10.1093/jn/131.3.1000S [DOI] [PubMed] [Google Scholar]
  81. Meng L., Zhang J., Song X., Zhou B., Gao F. (2016). Study on the function of lowering blood lipid of garlic oil. Chin. J. Public Health Eng. 15, 247–249. [Google Scholar]
  82. Miao Q., Wang R., Bai D., Xue X., Xu J., Sun X., et al. (2020). Antiatherosclerosis properties of total saponins of garlic in rats. Evid. Based Complement. Altern. Med. 2020, 3683659. 10.1155/2020/3683659 [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Miki S., Inokuma K. I., Takashima M., Nishida M., Sasaki Y., Ushijima M., et al. (2017). Aged garlic extract suppresses the increase of plasma glycated albumin level and enhances the AMP-activated protein kinase in adipose tissue in TSOD mice. Mol. Nutr. Food Res. 61, 1. 10.1002/mnfr.201600797 [DOI] [PubMed] [Google Scholar]
  84. Miki S., Suzuki J. I., Takashima M., Ishida M., Kokubo H., Yoshizumi M. (2021). S-1-Propenylcysteine promotes IL-10-induced M2c macrophage polarization through prolonged activation of IL-10R/STAT3 signaling. Sci. Rep. 11, 22469. 10.1038/s41598-021-01866-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Mohammad S. F., Woodward S. C. (1986). Characterization of a potent inhibitor of platelet aggregation and release reaction isolated from allium sativum (garlic). Thromb. Res. 44, 793–806. 10.1016/0049-3848(86)90025-3 [DOI] [PubMed] [Google Scholar]
  86. Moosavian S. P., Arab A., Paknahad Z., Moradi S. (2020). The effects of garlic supplementation on oxidative stress markers: A systematic review and meta-analysis of randomized controlled trials. Complement. Ther. Med. 50, 102385. 10.1016/j.ctim.2020.102385 [DOI] [PubMed] [Google Scholar]
  87. Morales-Ruiz M., Fulton D., Sowa G., Languino L. R., Fujio Y., Walsh K., et al. (2000). Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ. Res. 86, 892–896. 10.1161/01.res.86.8.892 [DOI] [PubMed] [Google Scholar]
  88. Morihara N., Hino A., Miki S., Takashima M., Suzuki J. I. (2017). Aged garlic extract suppresses inflammation in apolipoprotein E-knockout mice. Mol. Nutr. Food Res. 61, 1. 10.1002/mnfr.201700308 [DOI] [PubMed] [Google Scholar]
  89. Myasoedova V. A., Kirichenko T. V., Melnichenko A. A., Orekhova V. A., Ravani A., Poggio P., et al. (2016). Anti-atherosclerotic effects of a phytoestrogen-rich herbal preparation in postmenopausal women. Int. J. Mol. Sci. 17 (8), 1318. 10.3390/ijms17081318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Nagini S. (2008). Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise. Anticancer Agents Med. Chem. 8, 313–321. 10.2174/187152008783961879 [DOI] [PubMed] [Google Scholar]
  91. Nie X., Li G., Jiang H. (2002). Influence of allitridi on plasm GMP-140, D-dimer, NO and NOS in treating angina Pectoris. Shanghai J. Traditional Chin. Med. 36, 7–8. 10.3969/j.issn.1007-1334.2002.04.003 [DOI] [Google Scholar]
  92. Nie X., Zhao Y., Shi D., Liu Y., Zhou Z., Su L., et al. (2013). Effect of allicin capsules on prognosis and endothelial function after PCI in patients with coronary artery disease combined with diabetes mellitus. Natl. Med. J. China 93, 2052–2055. 10.3760/cma.j.issn.0376-2491.2013.26.010 [DOI] [PubMed] [Google Scholar]
  93. Nikolic D., Calderon L., Du L., Post S. R. (2011). SR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation. BMC Immunol. 12, 37. 10.1186/1471-2172-12-37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Okue S., Yaguchi M., Miura A., Ozaki-Masuzawa Y., Hosono T., Seki T. (2022). The garlic-derived organosulfur compound diallyl trisulphide suppresses tissue factor function. Food Funct. 13, 1246–1255. 10.1039/d1fo02206g [DOI] [PubMed] [Google Scholar]
  95. Omeish A. F., Abbadi W., Ghanma I. M., Drabaa Z., Botoosh F. A., Seif A., et al. (2011). Hospital-based study on the use of herbal medicine in patients with coronary artery disease in Jordan. JPMA. J. Pak. Med. Assoc. 61, 683–687. [PubMed] [Google Scholar]
  96. Orekhov A. N., Tertov V. V. (1997). In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells. Lipids 32, 1055–1060. 10.1007/s11745-997-0136-7 [DOI] [PubMed] [Google Scholar]
  97. Panyod S., Wu W. K., Chen P. C., Chong K. V., Yang Y. T., Chuang H. L., et al. (2022). Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation. NPJ Biofilms Microbiomes 8, 4. 10.1038/s41522-022-00266-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Peng J., Chen H., Qiao Y., Ma L., Takao N., Suzuki H., et al. (1996). Two new steroidal saponin components from garlic and their effects on blood coagulation. Acta Pharm. Sin. 31, 607–612. 10.3321/j.issn:0513-4870.1996.08.009 [DOI] [PubMed] [Google Scholar]
  99. Perez A., Gonzalez-Manzano S., Jimenez R., Perez-Abud R., Haro J. M., Osuna A., et al. (2014). The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: Correlation with beta-glucuronidase activity. Pharmacol. Res. 89, 11–18. 10.1016/j.phrs.2014.07.005 [DOI] [PubMed] [Google Scholar]
  100. Petrovic V., Nepal A., Olaisen C., Bachke S., Hira J., Søgaard C. K., et al. (2018). Anti-Cancer potential of homemade fresh garlic extract is related to increased endoplasmic reticulum stress. Nutrients 10, 450. 10.3390/nu10040450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Pi X., Xie L., Patterson C. (2018). Emerging roles of vascular endothelium in metabolic homeostasis. Circ. Res. 123, 477–494. 10.1161/CIRCRESAHA.118.313237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Piasek A., Bartoszek A., Namieśnik J. (2009). Phytochemicals that counteract the cardiotoxic side effects of cancer chemotherapy. Postepy Hig. Med. Dosw (Online). 63, 142–158. [PubMed] [Google Scholar]
  103. Qidwai W., Alim S. R., Dhanani R. H., Jehangir S., Nasrullah A., Raza A. (2003). Use of home remedies among patients presenting to family physicians. J. Coll. Physicians Surg. Pak 13, 62–63. [PubMed] [Google Scholar]
  104. Rahman K., Lowe G. M., Smith S. (2016). Aged garlic extract inhibits human platelet aggregation by altering intracellular signaling and platelet shape change. J. Nutr. 146, 410S–415S. 10.3945/jn.114.202408 [DOI] [PubMed] [Google Scholar]
  105. Rana S. V., Pal R., Vaiphei K., Sharma S. K., Ola R. P. (2011). Garlic in health and disease. Nutr. Res. Rev. 24, 60–71. 10.1017/S0954422410000338 [DOI] [PubMed] [Google Scholar]
  106. Rassoul F., Salvetter J., Reissig D., Schneider W., Thiery J., Richter V. (2006). The influence of garlic (Allium sativum) extract on interleukin 1alpha-induced expression of endothelial intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Phytomedicine 13, 230–235. 10.1016/j.phymed.2005.01.010 [DOI] [PubMed] [Google Scholar]
  107. Ried K. (2016). Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: An updated meta-analysis and review. J. Nutr. 146, 389S–396S. 10.3945/jn.114.202192 [DOI] [PubMed] [Google Scholar]
  108. Rose K. D., Croissant P. D., Parliament C. F., Levin M. B. (1990). Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report. Neurosurgery 26, 880–882. 10.1097/00006123-199005000-00026 [DOI] [PubMed] [Google Scholar]
  109. Rouf R., Uddin S. J., Sarker D. K., Islam M. T., Ali E. S., Shilpi J. A., et al. (2020). Antiviral potential of garlic (allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data. Trends Food Sci. Technol. 104, 219–234. 10.1016/j.tifs.2020.08.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Salehi B., Zucca P., Orhan I. E., Azzini E., Adetunji C. O., Mohammed S. A., et al. (2019). Allicin and health: A comprehensive review. Trends Food Sci. Technol. 1, 1. 10.1016/j.tifs.2019.03.003 [DOI] [Google Scholar]
  111. Salgado B., Monteiro L., Rocha N. (2011). Allium species poisoning in dogs and cats. J. Venom. Anim. Toxins Incl. Trop. Dis. 17, 4–11. 10.1590/S1678-91992011000100002 [DOI] [Google Scholar]
  112. Sela U., Brill A., Kalchenko V., Dashevsky O., Hershkoviz R. (2008). Allicin inhibits blood vessel growth and downregulates Akt phosphorylation and actin polymerization. Nutr. Cancer 60, 412–420. 10.1080/01635580701733083 [DOI] [PubMed] [Google Scholar]
  113. Sharifi M., Futema M., Nair D., Humphries S. E. (2019). Polygenic hypercholesterolemia and cardiovascular disease risk. Curr. Cardiol. Rep. 21, 43. 10.1007/s11886-019-1130-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Siegel-Axel D., Daub K., Seizer P., Lindemann S., Gawaz M. (2008). Platelet lipoprotein interplay: Trigger of foam cell formation and driver of atherosclerosis. Cardiovasc. Res. 78, 8–17. 10.1093/cvr/cvn015 [DOI] [PubMed] [Google Scholar]
  115. Sluimer J. C., Daemen M. J. (2009). Novel concepts in atherogenesis: Angiogenesis and hypoxia in atherosclerosis. J. Pathol. 218, 7–29. 10.1002/path.2518 [DOI] [PubMed] [Google Scholar]
  116. Sluimer J. C., Kolodgie F. D., Bijnens A. P., Maxfield K., Pacheco E., Kutys B., et al. (2009). Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J. Am. Coll. Cardiol. 53, 1517–1527. 10.1016/j.jacc.2008.12.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Sobenin I. A., Pryanishnikov V. V., Kunnova L. M., Rabinovich Y. A., Martirosyan D. M., Orekhov A. N. (2010). The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease. Lipids Health Dis. 9, 119. 10.1186/1476-511X-9-119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Srivastava K. C. (1986). Evidence for the mechanism by which garlic inhibits platelet aggregation. Prostagl. Leukot. Med. 22, 313–321. 10.1016/0262-1746(86)90142-3 [DOI] [PubMed] [Google Scholar]
  119. Sumara G., Belwal M., Ricci R. (2005). Jnking" atherosclerosis. Cell. Mol. Life Sci. 62, 2487–2494. 10.1007/s00018-005-5253-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Suo R., Zhao Z. Z., Tang Z. H., Ren Z., Liu X., Liu L. S., et al. (2013). Hydrogen sulfide prevents H₂O₂-induced senescence in human umbilical vein endothelial cells through SIRT1 activation. Mol. Med. Rep. 7, 1865–1870. 10.3892/mmr.2013.1417 [DOI] [PubMed] [Google Scholar]
  121. Szulińska M., Kręgielska-Narożna M., Świątek J., Styś P., Kuźnar-Kamińska B., Jakubowski H., et al. (2018). Garlic extract favorably modifies markers of endothelial function in obese patients -randomized double blind placebo-controlled nutritional intervention. Biomed. Pharmacother. = Biomedecine Pharmacother. 102, 792–797. 10.1016/j.biopha.2018.03.131 [DOI] [PubMed] [Google Scholar]
  122. Tabas I., García-Cardeña G., Owens G. K. (2015). Recent insights into the cellular biology of atherosclerosis. J. Cell Biol. 209, 13–22. 10.1083/jcb.201412052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Tabas I., Lichtman A. H. (2017). Monocyte-Macrophages and T Cells in atherosclerosis. Immunity 47, 621–634. 10.1016/j.immuni.2017.09.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Takashima M., Kanamori Y., Kodera Y., Morihara N., Tamura K. (2017). Aged garlic extract exerts endothelium-dependent vasorelaxant effect on rat aorta by increasing nitric oxide production. Phytomedicine 24, 56–61. 10.1016/j.phymed.2016.11.016 [DOI] [PubMed] [Google Scholar]
  125. Tocmo R., Wu Y., Liang D., Fogliano V., Huang D. (2017). Boiling enriches the linear polysulfides and the hydrogen sulfide-releasing activity of garlic. Food Chem. 221, 1867–1873. 10.1016/j.foodchem.2016.10.076 [DOI] [PubMed] [Google Scholar]
  126. Twigg M. W., Freestone K., Homer-Vanniasinkam S., Ponnambalam S. (2012). The LOX-1 scavenger receptor and its implications in the treatment of vascular disease. Cardiol. Res. Pract. 2012, 632408. 10.1155/2012/632408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. van Greevenbroek M. M., Robertus-Teunissen M. G., Erkelens D. W., de Bruin T. W. (1998). Participation of the microsomal triglyceride transfer protein in lipoprotein assembly in caco-2 cells: Interaction with saturated and unsaturated dietary fatty acids. J. Lipid Res. 39, 173–185. 10.1016/s0022-2275(20)34213-9 [DOI] [PubMed] [Google Scholar]
  128. Wang H. H., Garruti G., Liu M., Portincasa P., Wang D. Q. (2017). Cholesterol and lipoprotein metabolism and atherosclerosis: Recent advances in reverse cholesterol transport. Ann. Hepatol. 16, s27–s42. 10.5604/01.3001.0010.5495 [DOI] [PubMed] [Google Scholar]
  129. Wang K., Fu N. (2009). Efficacy of allicin for restenosis of geriatric myocardial infarction after percutaneous coronary intervention. China Pharm. 20, 2141–2143. 10.1097/mca.0b013e32832e5c61 [DOI] [Google Scholar]
  130. Wang L., Zhang J., Hu Y., Zhang H. (2017). Effects and mechanisms of allicin on atherosclerosis in high-fat diet fed mice. Chin. J. Arteriosclerosis 25, 140–144. [Google Scholar]
  131. Wang Q., Ma X., Li X., Li M., Yu T., Liu Z., et al. (2019). Hypolipidemic effect and antioxidation mechanism of diallyl disulfide in rats with hyperlipidemia. J. Toxicol. 33, 55–62. [Google Scholar]
  132. Weiner L., Shin I., Shimon L. J., Miron T., Wilchek M., Mirelman D., et al. (2009). Thiol-disulfide organization in alliin lyase (alliinase) from garlic (Allium sativum). Protein Sci. 18, 196–205. 10.1002/pro.10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Williams M. J., Sutherland W. H., McCormick M. P., Yeoman D. J., de Jong S. A. (2005). Aged garlic extract improves endothelial function in men with coronary artery disease. Phytother. Res. 19, 314–319. 10.1002/ptr.1663 [DOI] [PubMed] [Google Scholar]
  134. Wlosinska M., Nilsson A. C., Hlebowicz J., Hauggaard A., Kjellin M., Fakhro M., et al. (2020). The effect of aged garlic extract on the atherosclerotic process - a randomized double-blind placebo-controlled trial. BMC Complement. Med. Ther. 20, 132. 10.1186/s12906-020-02932-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Wojcikowski K., Myers S., Brooks L. (2007). Effects of garlic oil on platelet aggregation: A double-blind placebo-controlled crossover study. Platelets 18, 29–34. 10.1080/09537100600800636 [DOI] [PubMed] [Google Scholar]
  136. Wu J., Xia S., Kalionis B., Wan W., Sun T. (2014). The role of oxidative stress and inflammation in cardiovascular aging. Biomed. Res. Int. 2014, 615312. 10.1155/2014/615312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Wu M. Y., Li C. J., Hou M. F., Chu P. Y. (2017). New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int. J. Mol. Sci. 18, 1. 10.3390/ijms18102034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Wu T. T., Gao Y., Zheng Y. Y., Ma Y. T., Xie X. (2018). Atherogenic index of plasma (AIP): A novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 17, 197. 10.1186/s12944-018-0828-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Xiao D., Li M., Herman-Antosiewicz A., Antosiewicz J., Xiao H., Lew K. L., et al. (2006). Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2. Nutr. Cancer 55, 94–107. 10.1207/s15327914nc5501_12 [DOI] [PubMed] [Google Scholar]
  140. Xie W., Du L. (2011). Diabetes is an inflammatory disease: Evidence from traditional Chinese medicines. Diabetes Obes. Metab. 13, 289–301. 10.1111/j.1463-1326.2010.01336.x [DOI] [PubMed] [Google Scholar]
  141. Xu W., Shi Y., Meng X., Zhang W., Gao T. (2020). Protective effect of allicin on heart and its influence on aortic morphology, cardiomyocyte calcium sensing receptor and apoptotic index in rats with coronary heart disease. Chin. J. Evidence-Based Cardiovasc. Med. 12, 1236–1239. 10.3969/j.issn.1674-4055.2020.10.19 [DOI] [Google Scholar]
  142. Yan C. K., Zeng F. D. (2004). Recent advances in research of garlic's chemical constituents and theirs pharmacological effects. Chin. New Drugs J. 13, 688–691. 10.3321/j.issn:1003-3734.2004.08.005 [DOI] [Google Scholar]
  143. Yang L., H X., S B., Guan M., Li X. (2021). Study on the reaction of garlic and uterine in the UPLC-MS/MS of garlic sausol. Life Sci. Instrum. 19, 66–71. 10.11967/2021191210 [DOI] [Google Scholar]
  144. Yang S., Yuan H. Q., Hao Y. M., Ren Z., Qu S. L., Liu L. S., et al. (2020). Macrophage polarization in atherosclerosis. Clin. Chim. Acta 501, 142–146. 10.1016/j.cca.2019.10.034 [DOI] [PubMed] [Google Scholar]
  145. Yao X. M., Song B. L., Wang C. H., Zhang W. J., Lin C. X., Li B. L. (2006). Human acyl-coenzyme A: Cholesterol aacyltransferase(ACAT). J. Shanghai Jiaot. Univ. Sci. 24, 108–115. 10.3969/j.issn.1671-9964.2006.01.023 [DOI] [Google Scholar]
  146. Zhai B., Zhang C., Sheng Y., Zhao C., He X., Xu W., et al. (2018). Hypoglycemic and hypolipidemic effect of S-allyl-cysteine sulfoxide (alliin) in DIO mice. Sci. Rep. 8, 3527. 10.1038/s41598-018-21421-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Zhang M., Pan H., Xu Y., Wang X., Qiu Z., Jiang L. (2017). Allicin decreases lipopolysaccharide-induced oxidative stress and inflammation in human umbilical vein endothelial cells through suppression of mitochondrial dysfunction and activation of Nrf2. Cell. Physiol. biochem. 41, 2255–2267. 10.1159/000475640 [DOI] [PubMed] [Google Scholar]
  148. Zhang T., Tong X., Liu X. (2007). Study on the antihyperlipidemia effect of allicin and the mechanism. Chin. J. Exp. Traditional Med. Formulae 13, 32–35. 10.3969/j.issn.1005-9903.2007.02.012 [DOI] [Google Scholar]
  149. Zhang W., Zhu T., Chen L., Luo W., Chao J. (2020). MCP-1 mediates ischemia-reperfusion-induced cardiomyocyte apoptosis via MCPIP1 and CaSR. Am. J. Physiol. Heart Circ. Physiol. 318, H59–H71. 10.1152/ajpheart.00308.2019 [DOI] [PubMed] [Google Scholar]
  150. Zhao D., Liu J., Wang M., Zhang X., Zhou M. (2019). Epidemiology of cardiovascular disease in China: Current features and implications. Nat. Rev. Cardiol. 16, 203–212. 10.1038/s41569-018-0119-4 [DOI] [PubMed] [Google Scholar]
  151. Zhu Y., Xian X., Wang Z., Bi Y., Chen Q., Han X., et al. (2018). Research progress on the relationship between atherosclerosis and inflammation. Biomolecules 8. 10.3390/biom8030080 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES